Up a level |
2023
Borchmann, Peter, Heger, Jan-Michel ORCID: 0000-0001-9463-8504, Mahlich, Jorg ORCID: 0000-0003-1110-2793, Papadimitrious, Michael S., Riou, Sybille and Werner, Barbara (2023). Healthcare Resource Utilization and Associated Costs of German Patients with Diffuse Large B-Cell Lymphoma: A Retrospective Health Claims Data Analysis. Oncol. Ther., 11 (1). S. 65 - 82. NEW YORK: SPRINGER. ISSN 2366-1089
Borrega, Jorge Garcia, Boell, Boris, Kochanek, Matthias, Naendrup, Jan-Hendrik, Simon, Florian, Sieg, Noelle, Hallek, Michael, Borchmann, Peter, Holtick, Udo, Shimabukuro-Vornhagen, Alexander, Eichenauer, Dennis A. and Heger, Jan-Michel ORCID: 0000-0001-9463-8504 (2023). Characteristics and outcomes of patients undergoing high-dose chemotherapy and autologous stem cell transplantation admitted to the intensive care unit: a single-center retrospective analysis. Ann. Hematol., 102 (1). S. 191 - 198. NEW YORK: SPRINGER. ISSN 1432-0584
2022
Bethge, Wolfgang A., Martus, Peter, Schmitt, Michael, Holtick, Udo, Subklewe, Marion, von Tresckow, Bastian ORCID: 0000-0003-1410-4487, Ayuk, Francis, Wagner-Drouet, Eva Marie, Wulf, Gerald G., Marks, Reinhard, Penack, Olaf, Schnetzke, Ulf, Koenecke, Christian, von Bonin, Malte ORCID: 0000-0002-2995-3230, Stelljes, Matthias, Glass, Bertram, Baldus, Claudia D., Vucinic, Vladan ORCID: 0000-0002-8398-285X, Mougiakakos, Dimitrios, Topp, Max, Fante, Matthias A., Schroers, Roland, Bayir, Lale, Borchmann, Peter, Buecklein, Veit, Hasenkamp, Justin, Hanoun, Christine, Thomas, Simone, Beelen, Dietrich W., Lengerke, Claudia, Kroeger, Nicolaus and Dreger, Peter (2022). GLA/DRST real-world outcome analysis of CAR T-cell therapies for large B-cell lymphoma in Germany. Blood, 140 (4). S. 349 - 359. WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020
Borchmann, Peter, Moccia, Alden, Greil, Richard, Hertzberg, Mark, Schaub, Valdete, Huettmann, Andreas, Keil, Felix, Dierlamm, Judith, Haenel, Mathias, Novak, Urban, Meissner, Julia, Zimmermann, Andreas, Mathas, Stephan, Zijlstra, Josee M., Fossa, Alexander, Viardot, Andreas, Hertenstein, Bernd, Martin, Sonja, Giri, Pratyush, Kamper, Peter, Molin, Daniel, Kreissl, Stefanie, Fuchs, Michael, Schneider, Gundolf, Rosenwald, Andreas, Klapper, Wolfram, Eich, Hans, Baues, Christian, Hallek, Michael, Dietlein, Markus, Kobe, Carsten, Diehl, Volker and Engert, Andreas (2022). Treatment Related Morbidity in Patients with Classical Hodgkin Lymphoma: Results of the Ongoing, Randomized Phase III HD21 Trial By the German Hodgkin Study Group. Blood, 140. WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020
Borchmann, Peter, Papadimitrious, Michael, Riou, Sybille, Mahlich, Joerg and Werner, Barbara (2022). Survival Patients Newly Diagnosed with Diffuse Large B-Cell Lymphoma (DLBCL) - Real World Evidence from Germany. Blood, 140. S. 7919 - 7920. WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020
Borchmann, Peter, Papadimitrious, Michael S., Mahlich, Joerg, Riou, Sybille and Werner, Barbara (2022). Healthcare Resource Utilization and Associated Costs of German Patients with Diffuse Large B-Cell Lymphoma (DLBCL) - a Retrospective Health Claims Data Analysis. Blood, 140. S. 7932 - 7933. WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020
Borchmann, Peter, Vandenberghe, Peter, Urbano-Ispizua, Alvaro, Haioun, Corinne, Lemonnier, Francois, Griskevicius, Laimonas, Maury, Sebastien, Holtkamp, Silke, Friedrichs, Birte, Zadoyan, Gregor, Hanssens, Linda, Overstijns, Toon, Assenmacher, Mario, Bethke, Ulf, Buerger, Iris, Reer, Olaf, Jaeger, Ulrich and Kersten, Marie Jose (2022). Trial in Progress: A Randomized Phase II Study of MB-CART2019.1 Compared to Standard of Care Therapy in Patients with Relapsed/Refractory DLBCL Ineligible for High-Dose Chemotherapy and Autologous Stem Cell Transplantation- DALY 2-EU Trial. Blood, 140. S. 12784 - 12786. WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020
Brockelmann, Paul J. and Borchmann, Peter (2022). Navigating increasingly individualised Hodgkin lymphoma treatments to optimally balance risks and benefits. Br. J. Haematol., 197 (5). S. 515 - 518. HOBOKEN: WILEY. ISSN 1365-2141
Broeckelmann, Paul J., Buehnen, Ina, Meissner, Julia, Trautmann-Grill, Karolin, Herhaus, Peter, Halbsguth, Teresa, V, Schaub, Valdete, Kerkhoff, Andrea, Mathas, Stephan, Bormann, Matthias, Dickhut, Andreas, Kaul, Helen, Fuchs, Michael, Kobe, Carsten, Baues, Christian, Borchmann, Peter, Engert, Andreas and von Tresckow, Bastian (2022). Nivolumab and AVD in Early-Stage Unfavorable Hodgkin Lymphoma: Follow-up Analysis of the Randomized GHSG Phase II Nivahl Trial. Blood, 140. S. 1753 - 1756. WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020
Broeckelmann, Paul J., Mueller, Horst, Gillessen, Sarah, Yang, Xiaoqin, Koeppel, Larissa, Pilz, Veronika, Marinello, Patricia, Kaskel, Peter, Raut, Monika, Fuchs, Michael, Borchmann, Peter, Engert, Andreas and von Tresckow, Bastian (2022). Clinical outcomes of relapsed and refractory Hodgkin lymphoma patients after contemporary first-line treatment: a German Hodgkin Study Group analysis. Leukemia, 36 (3). S. 772 - 781. LONDON: SPRINGERNATURE. ISSN 1476-5551
Damaschin, Carla, Goergen, Helen, Kreissl, Stefanie, Pluetschow, Annette, Breywisch, Frank, Mathas, Stephan, Meissner, Julia, Soekler, Martin, Topp, Max S., Vucinic, Vladan, Zimmermann, Andreas, von Tresckow, Bastian, Fuchs, Michael, Engert, Andreas, Borchmann, Peter and Eichenauer, Dennis A. (2022). Brentuximab vedotin-containing escalated BEACOPP variants for newly diagnosed advanced-stage classical Hodgkin lymphoma: follow-up analysis of a randomized phase II study from the German Hodgkin Study Group. Leukemia, 36 (2). S. 580 - 583. LONDON: SPRINGERNATURE. ISSN 1476-5551
Eichenauer, Dennis A. ORCID: 0000-0002-1927-3514, Buehnen, Ina, Pluetschow, Annette, Kobe, Carsten, Dietlein, Markus, Wendtner, Clemens-Martin, Thorspecken, Sven, Topp, Max S., Mauser, Mareike, von Tresckow, Bastian, Fuchs, Michael, Borchmann, Peter and Engert, Andreas (2022). Phase II study of fixed-duration single-agent ibrutinib in relapsed nodular lymphocyte-predominant Hodgkin lymphoma: A report from the German Hodgkin Study Group. Hematol. Oncol., 40 (4). S. 801 - 805. HOBOKEN: WILEY. ISSN 1099-1069
Eichenauer, Dennis A. ORCID: 0000-0002-1927-3514, Buhnen, Ina, Kreissl, Stefanie, Goergen, Helen, Fuchs, Michael, von Tresckow, Bastian, Rosenwald, Andreas, Klapper, Wolfram, Hansmann, Martin-Leo, Moller, Peter, Bernd, Heinz-Wolfram, Feller, Alfred C., Engert, Andreas, Borchmann, Peter and Hartmann, Sylvia (2022). Histopathological growth patterns in patients with advanced nodular lymphocyte-predominant Hodgkin lymphoma treated within the randomized HD18 study: a report from the German Hodgkin Study Group. Br. J. Haematol., 196 (1). S. 99 - 105. HOBOKEN: WILEY. ISSN 1365-2141
Garcia-Marquez, Maria A., Thelen, Martin ORCID: 0000-0002-2785-9726, Reinke, Sarah, Keller, Diandra, Wennhold, Kerstin, Lehmann, Jonas, Veldman, Johanna ORCID: 0000-0003-4253-0870, Borchmann, Sven ORCID: 0000-0001-6662-6864, Rosenwald, Andreas, Sasse, Stephanie, Diepstra, Arjan ORCID: 0000-0001-9239-1050, Borchmann, Peter, Engert, Andreas, Klapper, Wolfram, Von Bergwelt-Baildon, Michael, Broeckelmann, Paul J. and Schloesser, Hans A. (2022). Reverted exhaustion phenotype of circulating lymphocytes as immune correlate of anti-PD1 first-line treatment in Hodgkin lymphoma. Leukemia, 36 (3). S. 760 - 772. LONDON: SPRINGERNATURE. ISSN 1476-5551
Gerhard-Hartmann, Elena ORCID: 0000-0003-2134-2774, Goergen, Helen, Broeckelmann, Paul J., Mottok, Anja, Steinmueller, Tabea ORCID: 0000-0001-7099-1223, Grund, Johanna, Zamo, Alberto, Ben-Neriah, Susana, Sasse, Stephanie, Borchmann, Sven ORCID: 0000-0001-6662-6864, Fuchs, Michael, Borchmann, Peter, Reinke, Sarah, Engert, Andreas, Veldman, Johanna ORCID: 0000-0003-4253-0870, Diepstra, Arjan ORCID: 0000-0001-9239-1050, Klapper, Wolfram and Rosenwald, Andreas (2022). 9p24.1 alterations and programmed cell death 1 ligand 1 expression in early stage unfavourable classical Hodgkin lymphoma: an analysis from the German Hodgkin Study Group NIVAHL trial. Br. J. Haematol., 196 (1). S. 116 - 127. HOBOKEN: WILEY. ISSN 1365-2141
Gillessen, Sarah, Huettmann, Andreas, Vucinic, Vladan, Mueller, Horst, Pluetschow, Annette, Viardot, Andreas, Topp, Max S., Kobe, Carsten, Boell, Boris, Eichenauer, Dennis A. ORCID: 0000-0002-1927-3514, Sasse, Stephanie, Haverkamp, Heinz, Schmitz, Christine, Borchmann, Sven, Broeckelmann, Paul J., Heger, Jan-Michel, Fushs, Michael, Engert, Andreas, Borchmann, Peter and von Tresckow, Bastian (2022). Reinduction therapy with everolimus in combination with dexamethasone, high-dose cytarabin and cisplatinum in patients with relapsed or refractory classical Hodgkin lymphoma: an experimental phase I/II multicentre trial of the German Hodgkin Study Group (GHSG HD-R3i). Br. J. Haematol., 196 (3). S. 606 - 617. HOBOKEN: WILEY. ISSN 1365-2141
Gillessen, Sarah, Pluetschow, Annette, Vucinic, Vladan ORCID: 0000-0002-8398-285X, Ostermann, Helmut, Kobe, Carsten, Broeckelmann, Paul J., Boell, Boris, Eichenauer, Dennis A., Heger, Jan-Michel ORCID: 0000-0001-9463-8504, Borchmann, Sven, Fuchs, Michael, Borchmann, Peter, Engert, Andreas and von Tresckow, Bastian (2022). JAK inhibition with ruxolitinib in relapsed or refractory classical Hodgkin lymphoma: Final results of a phase II, open label, multicentre clinical trial (JeRiCHO). Eur. J. Haematol., 109 (6). S. 728 - 736. HOBOKEN: WILEY. ISSN 1600-0609
Graef, Claus Moritz, Goedel, Philipp, Falderbaum, Philipp, Balke-Want, Hyatt, Simon, Florian ORCID: 0000-0002-2700-3717, Sieg, Noelle, Naendrup, Jan-Hendrik, Neumann, Marie Anne-Catherine ORCID: 0000-0002-2396-6110, Gillessen, Sarah, Broeckelmann, Paul J., Eichenauer, Dennis A., Borchmann, Peter, von Tresckow, Bastian and Heger, Jan-Michel ORCID: 0000-0001-9463-8504 (2022). Impact of timing and precision of histopathological diagnosis on outcomes of patients with Burkitt lymphoma and high-grade B-cell lymphoma. Eur. J. Haematol., 108 (5). S. 403 - 413. HOBOKEN: WILEY. ISSN 1600-0609
Hartmann, Sylvia, Soltani, Ahmad Sajad, Bankov, Katrin ORCID: 0009-0005-4033-4966, Bein, Julia, Hansmann, Martin-Leo, Rosenwald, Andreas, Bernd, Heinz-Wolfram, Feller, Alfred, Ott, German, Moeller, Peter, Stein, Harald, Klapper, Wolfram, Borchmann, Peter, Engert, Andreas and Eichenauer, Dennis A. (2022). Tumour cell characteristics and microenvironment composition correspond to clinical presentation in newly diagnosed nodular lymphocyte-predominant Hodgkin lymphoma. Br. J. Haematol., 199 (3). S. 382 - 392. HOBOKEN: WILEY. ISSN 1365-2141
Heger, Jan-Michel, Mattlener, Julia, Godel, Philipp, Balke-Want, Hyatt, Sieg, Noelle, Kutsch, Nadine, Becker, Kerstin, Weiss, Jonathan, Reinhardt, H. Christian, Hallek, Michael, Borchmann, Peter, von Tresckow, Bastian and Borchmann, Sven (2022). Noninvasive, Dynamic Risk Profiling of Primary Central Nervous System Lymphoma By Peripheral Blood Ctdna-Sequencing. Blood, 140. S. 3537 - 3539. WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020
Holzer, Tatjana, Biedermann, Stefanie, Herfort, Inga, Friedrichs, Birte, Holtkamp, Silke, Hanssens, Linda, Assenmacher, Mario, Bethke, Ulf, Schneider, Dina, Miltenyi, Stefan, Overstijns, Toon, Schmid, Christoph, Ayuk, Francis A., Scheid, Christoph, Juehling, Anja, Holtick, Udo, Goedel, Philipp, Borchmann, Peter and Buerger, Iris (2022). Characterization and T-Cell Repertoire of MB-CART2019.1 (Zamtocabtagene autoleucel) - Data from the Phase I Trial in Patients with Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma. Blood, 140. S. 4581 - 4584. WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020
Illerhaus, Gerald, Farreri, Andres J. M., Binder, Mascha, Borchmann, Peter, Hasenkamp, Justin, Stilgenbauer, Stephan, Roeth, Alexander, Webern, Thomas, Egerer, Gerlinde, Ernst, Thomas, Hertenstein, Bernd, Lenz, Georg, Kobbe, Guido, Brunnberg, Uta, Schmidt, Christian, Kneba, Michael, Dreyling, Martin, Moehle, Robert, Panse, Jens, Heinicke, Thomas, Schroll, Sebastian, Larsen, Thomas S., Salwender, Hans, Naumann, Ralph, Hess, Georg, Thurner, Lorenz, Pukrop, Tobias, Keller, Ulrich, Blystadt, Anne Kirsti, Kroschinsky, Frank P., Re, Francesca, Pulczynski, Elisa, Orsucci, Lorella, Pospiech, Lisa, Deckert, Martina, Ponzoni, Maurilio, Wendler, Julia, Valk, Elke, Calimeri, Teresa, Kasenda, Benjamin, Trepel, Martin, Fricker, Heidi, von Gottberg, Philipp, Burger, Elvira, Ihorst, Gabriele, Grishina, Olga, Hader, Claudia, Zucca, Emanuele, Finke, Juergen and Schorb, Elisabeth (2022). Effects on Survival of Non-Myeloablative Chemoimmunotherapy Compared to High-Dose Chemotherapy Followed By Autologous Stem Cell Transplantation (HDC-ASCT) As Consolidation Therapy in Patients with Primary CNS Lymphoma - Results of an International Randomized Phase III Trial (MATRix/IELSG43). Blood, 140. S. 10 - 14. WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020
Jacob, Anne Sophie, Kaul, Helen, Fuchs, Michael, Gillessen, Sarah, Kreissl, Stefanie, Pluetschow, Annette, Momotow, Jesko, Schaub, Valdete, Huettmann, Andreas, Haenel, Mathias, Zimmermann, Andreas, Dierlamm, Judith, Meissner, Julia, Mathas, Stephan, Martin, Sonja, Engert, Andreas, Hallek, Michael ORCID: 0000-0002-7425-4455, Borchmann, Peter and Lehmann, Clara (2022). Impact of the first COVID-19 lockdown in Germany on the rate of acute infections during intensive chemotherapy for Hodgkin lymphoma. Infection, 50 (4). S. 925 - 933. HEIDELBERG: SPRINGER HEIDELBERG. ISSN 1439-0973
Jaeger, Ulrich, Tam, Constantine S., Borchmann, Peter, McGuirk, Joseph P., Johansen, Marianne, Waller, Edmund K., Jaglowski, Samantha ORCID: 0000-0002-4335-2554, Andreadis, Charalambos, Foley, Stephen R., Westin, Jason R., Fleury, Isabelle, Ho, P. Joy, Mielke, Stephan ORCID: 0000-0002-8325-9215, Teshima, Takanori, Salles, Gilles, Schuster, Stephen J., He, Fiona, Maziarz, Richard T., Mayer, Sebastian, Makita, Shinichi, Kersten, Marie J., Ghosh, Monalisa, Wagner-Johnston, Nina, Kato, Koji, Corradini, Paolo, Goto, Hideki, Colicino, Silvia, Agarwal, Abhijit, Lobetti-Bodoni, Chiara and Bishop, Michael R. (2022). Long-term safety for patients with tisagenlecleucel-treated relapsed/refractory diffuse large B-cell lymphoma. Blood Adv., 6 (16). S. 4816 - 4821. AMSTERDAM: ELSEVIER. ISSN 2473-9537
Kaddu-Mulindwa, Dominic ORCID: 0000-0001-8832-252X, Godel, Philipp, Kutsch, Nadine, Heger, Jan-Michel ORCID: 0000-0001-9463-8504, Scheid, Christof, Borchmann, Peter, Holtick, Udo, Held, Gerhard, Thurner, Lorenz, Bewarder, Moritz, Rixecker, Torben and Bittenbring, Joerg-Thomas (2022). Salvage High-dose Melphalan With Autologous Stem cell Transplantation as Bridge to Consolidation Therapy for Chemoresistant Aggressive B-cell Lymphoma. Clin. Lymphoma Myeloma Leuk., 22 (7). S. E498 - 9. DALLAS: CIG MEDIA GROUP, LP. ISSN 2152-2669
Kobe, Carsten, Baues, Christian, Borchmann, Sven, Fuchs, Michael, Borchmann, Peter, Eich, Hans-Theodor and Dietlein, Markus (2022). FDG-positron emission tomography/computed tomography and new opportunities for risk stratification. Onkologie, 28 (10). S. 853 - 862. HEIDELBERG: SPRINGER HEIDELBERG. ISSN 2731-7234
Kutsch, Nadine, Goedel, Philipp, Holtick, Udo, Lohneis, Anja, Vucinic, Vladan, Altefrohne, Florentine Pia, Schubert, Christin, Karitzky, Sandra, Hanssens, Linda, Assenmacher, Mario, Buerger, Iris, Aktas, Murat and Borchmann, Peter (2022). A Phase I Dose Finding Trial of MB-CART20.1 in Patients with Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma. Blood, 140. S. 12980 - 12982. WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020
Kutsch, Nadine, Goedel, Philipp, Voltin, Conrad-Amadeus, Kobe, Carsten, Hallek, Michael ORCID: 0000-0002-7425-4455, Scheid, Christof, Borchmann, Peter and Holtick, Udo (2022). Sustained Remission of Relapsed Diffuse Large B-cell Lymphoma After Safe Administration of CD19-directed CAR T-cells in a Patient With Chronic Intestinal and Pulmonal GvHD. Hemasphere, 6 (7). PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS. ISSN 2572-9241
Lang, Katharina M., Bereczky, Tamas, Geissler, Jan ORCID: 0000-0001-9058-5097, Bolanos, Natacha, Morgan, Kathryn E., Plate, Ananda, Vallejo, Ana, Wintrich, Sophie, York, Nick, Loffelhardt, Peter, Huntly, Brian, Sonneveld, Pieter, Boccadoro, Mario, Santini, Valeria, Pospisilova, Sarka, Hochhaus, Andreas, Barbui, Tiziano, Borchmann, Peter, Buske, Christian, Guillevic, Yann, Calado, Frederico, Harrison, Katy, Dawoud, Dalia, Sanz, Guillermo, Hernandez, Jesus Maria, De Waal, Ellen, Barbus, Martje, Schulze-Rath, Renate and Bullinger, Lars (2022). Pan-Stakeholder Core Outcome Set (COS) Definition for Hematological Malignancies within the Framework of Harmony and Harmony PLUS Projects. Blood, 140. S. 5285 - 5288. WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020
Malin, Jakob J. ORCID: 0000-0002-2989-0436, Di Cristanziano, Veronica, Horn, Carola, Pracht, Elisabeth, Borrega, Jorge Garcia, Heger, Eva, Knops, Elena ORCID: 0000-0001-7398-3026, Kaiser, Rolf, Boll, Boris, Lehmann, Clara, Jung, Norma, Borchmann, Peter, Fatkenheuer, Gerd, Klein, Florian ORCID: 0000-0003-1376-1792, Hallek, Michael ORCID: 0000-0002-7425-4455 and Rybniker, Jan (2022). SARS-CoV-2-neutralizing antibody treatment in patients with COVID-19 and immunodeficiency due to B-cell non-Hodgkin lymphoma. Blood Adv., 6 (5). S. 1580 - 1585. AMSTERDAM: ELSEVIER. ISSN 2473-9537
Momotow, Jesko, Buehnen, Ina, Trautmann-Grill, Karolin, Kobbe, Guido, Hahn, Dennis, Schroers, Roland ORCID: 0000-0003-2744-5491, Heinrich, Bernhard, Gaska, Tobias, Forstbauer, Helmut, Schmidt, Burkhard, Boger, Regina, Huettmann, Andreas, Heil, Gerhard, Kraemer, Doris M., Krueger, William, Zeremski, Vanja, Grobe, Norbert, Jentsch-Ullrich, Kathleen, Griesinger, Frank, Fuchs, Michael, von Tresckow, Bastian, Borchmann, Peter, Engert, Andreas and Broeckelmann, Paul J. (2022). Outcomes of anti-programmed death 1 treatment for relapsed/refractory Hodgkin lymphoma: A German Hodgkin Study Group multicentre real-world analysis. Br. J. Haematol., 198 (2). S. 401 - 405. HOBOKEN: WILEY. ISSN 1365-2141
Rosenbrock, Johannes, Baues, Christian, Vasquez-Torres, Andres, Clivio, Alessandro, Fogliata, Antonella, Borchmann, Peter, Marnitz, Simone and Cozzi, Luca (2022). Volumetric modulated arc therapy versus intensity-modulated proton therapy in the irradiation of infra diaphragmatic Hodgkin Lymphoma in female patients. Acta Oncol., 61 (1). S. 81 - 89. ABINGDON: TAYLOR & FRANCIS LTD. ISSN 1651-226X
Sasse, Stephanie, Brockelmann, Paul Jan, Momotow, Jesko, Plutschow, Annette, Huttmann, Andreas, Basara, Nadezda, Koenecke, Christian, Martin, Sonja, Bentz, Martin, Grosse-Thie, Christina, Thorspecken, Sven, de Wit, Maike, Kobe, Carsten, Dietlein, Markus, v Tresckow, Bastian, Fuchs, Michael, Borchmann, Peter and Engert, Andreas (2022). AFM13 in patients with relapsed or refractory classical Hodgkin lymphoma: final results of an open-label, randomized, multicenter phase II trial. Leuk. Lymphoma, 63 (8). S. 1871 - 1879. ABINGDON: TAYLOR & FRANCIS LTD. ISSN 1029-2403
Schorb, Elisabeth, Isbell, Lisa, Kerkhoff, Andrea, Mathas, Stephan, Braulke, Friederike, Egerer, Gerlinde, Roeth, Alexander, Schliffke, Simon Christian, Borchmann, Peter, Brunnberg, Uta, Kroschinsky, Frank P., Moehle, Robert, Rank, Andreas, Wellnitz, Dominique, Kasenda, Benjamin, Pospiech, Lisa, Wendler, Julia, Ihorst, Gabriele, Scherer, Florian, Deckert, Martina, Henkes, Elina, Duyster, Justus, Finke, Juergen and Illerhaus, Gerald (2022). High-Dose Chemotherapy and Autologous Stem Cell Transplant in Elderly and Fit Primary CNS Lymphoma Patients - a Multicenter Study By the Cooperative PCNSL Study Group (MARTA study). Blood, 140. S. 1773 - 1775. WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020
van Heek, Lutz, Stuka, Colin, Kaul, Helen, Mueller, Horst, Mettler, Jasmin, Hitz, Felicitas, Baues, Christian, Fuchs, Michael, Borchmann, Peter, Engert, Andreas, Dietlein, Markus, Voltin, Conrad-Amadeus and Kobe, Carsten (2022). Predictive value of baseline metabolic tumor volume in early-stage favorable Hodgkin Lymphoma - Data from the prospective, multicenter phase III HD16 trial. BMC Cancer, 22 (1). LONDON: BMC. ISSN 1471-2407
2021
Baues, Christian, Goergen, Helen, Fuchs, Michael, Rosenbrock, Johannes, Celik, Eren, Eich, Hans, Kobe, Carsten, Voltin, Conrad-Amadeus, Engert, Andreas, Borchmann, Peter and Marnitz, Simone (2021). Involved-Field Radiation Therapy Prevents Recurrences in the Early Stages of Hodgkin Lymphoma in PET-Negative Patients After ABVD Chemotherapy: Relapse Analysis of GHSG Phase 3 HD16 Trial. Int. J. Radiat. Oncol. Biol. Phys., 111 (4). S. 900 - 907. NEW YORK: ELSEVIER SCIENCE INC. ISSN 1879-355X
Bishop, Michael R., Dickinson, Michael, Purtill, Duncan, Barba, Pere, Santoro, Armando, Hamad, Nada, Kato, Koji, Sureda, Anna, Greil, Richard, Thieblemont, Catherine, Morschhauser, Franck, Janz, Martin, Flinn, Ian W., Rabitsch, Werner, Kwong, Yok Lam, Kersten, Marie Jose, Minnema, Monique C., Holte, Harald, Chan, Esther Hian Li, Martinez-Lopez, Joaquin, Mueller, Antonia M. S., Maziarz, Richard T., McGuirk, Joseph P., Bachy, Emmanuel, Le Gouill, Steven, Dreyling, Martin, Harigae, Hideo, Bond, David A., Andreadis, Charalambos, McSweeney, Peter A., Kharfan-Dabaja, Mohamed A., Newsome, Simon, Degtyarev, Evgeny, Del Corral, Chris, Andreola, Giovanna, Masood, Aisha, Schuster, Stephen J., Jaeger, Ulrich, Borchmann, Peter and Westin, Jason R. (2021). Tisagenlecleucel Vs Standard of Care As Second-Line Therapy of Primary Refractory or Relapsed Aggressive B-Cell Non-Hodgkin Lymphoma: Analysis of the Phase III Belinda Study. Blood, 138. WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020
Brockelmann, Paul J., Muller, Horst, Guhl, Teresa, Behringer, Karolin, Fuchs, Michael ORCID: 0000-0003-3289-3272, Moccia, Alden A., Rank, Andreas, Soekler, Martin, Vieler, Tom, Pabst, Thomas, Baues, Christian, von Tresckow, Bastian, Borchmann, Peter and Engert, Andreas (2021). Relapse After Early-Stage, Favorable Hodgkin Lymphoma: Disease Characteristics and Outcomes With Conventional or High-Dose Chemotherapy. J. Clin. Oncol., 39 (2). S. 107 - 122. PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS. ISSN 1527-7755
Eichenauer, Dennis A. ORCID: 0000-0002-1927-3514, Muller, Horst, Elger, Leonard, Goergen, Helen, Fuchs, Michael, Kreissl, Stefanie, Boll, Boris, Diehl, Volker, von Tresckow, Bastian, Borchmann, Peter and Engert, Andreas (2021). Non-Hodgkin lymphoma after treatment for classical Hodgkin lymphoma: a report from the German Hodgkin Study Group. Br. J. Haematol., 193 (3). S. 515 - 520. HOBOKEN: WILEY. ISSN 1365-2141
Ernst, Moritz ORCID: 0000-0003-0360-913X, Oeser, Annika, Besiroglu, Burcu, Caro-Valenzuela, Julia, Aziz, Mohamed Abd El, Monsef, Ina, Borchmann, Peter, Estcourt, Lise J., Skoetz, Nicole and Goldkuhle, Marius (2021). Chimeric antigen receptor (CAR) T-cell therapy for people with relapsed or refractory diffuse large B-cell lymphoma. Cochrane Database Syst Rev. (9). HOBOKEN: WILEY. ISSN 1361-6137
Frontzek, Fabian ORCID: 0000-0003-1705-3638, Ziepert, Marita, Nickelsen, Maike, Altmann, Bettina, Glass, Bertram, Haenel, Mathias, Truemper, Lorenz, Held, Gerhard, Bentz, Martin, Borchmann, Peter, Dreyling, Martin, Viardot, Andreas, Kroschinsky, Frank P., Metzner, Bernd, Staiger, Annette M., Horn, Heike, Ott, German, Rosenwald, Andreas, Loeffler, Markus, Lenz, Georg and Schmitz, Norbert (2021). Rituximab plus high-dose chemotherapy (MegaCHOEP) or conventional chemotherapy (CHOEP-14) in young, high-risk patients with aggressive B-cell lymphoma: 10-year follow-up of a randomised, open-label, phase 3 trial. Lancet Haematol., 8 (4). S. E267 - 11. OXFORD: ELSEVIER SCI LTD. ISSN 2352-3026
Goedel, Philipp, Sieg, Noelle, Heger, Jan-Michel, Kutsch, Nadine, Herling, Carmen, Baermann, Ben-Niklas, Scheid, Christof, Borchmann, Peter and Holtick, Udo (2021). Hematologic Rescue of CAR T-cell-mediated Prolonged Pancytopenia Using Autologous Peripheral Blood Hematopoietic Stem Cells in a Lymphoma Patient. Hemasphere, 5 (3). PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS. ISSN 2572-9241
Jachimowicz, Ron D., Klapper, Wolfram, Glehr, Gunther ORCID: 0000-0002-1495-9162, Mueller, Horst, Haverkamp, Heinz, Thorns, Christoph, Hansmann, Martin Leo, Moeller, Peter, Stein, Harald, Rehberg, Thorsten, von Tresckow, Bastian, Reinhardt, H. C., Borchmann, Peter, Chan, Fong Chun, Spang, Rainer, Scott, David W., Engert, Andreas, Steidl, Christian, Altenbuchinger, Michael and Rosenwald, Andreas (2021). Gene expression-based outcome prediction in advanced stage classical Hodgkin lymphoma treated with BEACOPP. Leukemia, 35 (12). S. 3589 - 3594. LONDON: SPRINGERNATURE. ISSN 1476-5551
Jachimowicz, Ron Daniel, Pieper, Luise, Reinke, Sarah, Gontarewicz, Artur, Pluetschow, Annette, Haverkamp, Heinz, Frauenfeld, Leonie, Fend, Falko, Overkamp, Mathis, Jochims, Franziska, Thorns, Christoph, Hansmann, Martin Leo, Moller, Peter, Rosenwald, Andreas, Stein, Harald, Reinhardt, Hans Christian, Borchmann, Peter, von Tresckow, Bastian, Engert, Andreas and Klapper, Wolfram (2021). Whole-slide image analysis of the tumor as a predictor of adverse outcome in patients with advanced-stage classical Hodgkin lymphoma treated with BEACOPP. Haematologica, 106 (6). S. 1684 - 1693. PAVIA: FERRATA STORTI FOUNDATION. ISSN 0390-6078
Jaeger, Ulrich, Worel, Nina, McGuirk, Joseph, Riedell, Peter A., Fleury, Isabelle, Borchmann, Peter, Du, Yan, Abdelhady, Ahmed M., Han, Xia, Martinez-Prieto, Marcela and Waller, Edmund K. (2021). Safety and efficacy of tisagenlecleucel (tisa-cel) plus pembrolizumab (pembro) in patients (pts) with relapsed/refractory diffuse large B-cell lymphoma (r/r DLBCL): Updated analysis of the phase 1b PORTIA study. J. Clin. Oncol., 39 (15). PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS. ISSN 1527-7755
Mueller, Karen Thudium, Grupp, Stephan A., Maude, Shannon L., Levine, John E., Pulsipher, Michael A., Boyer, Michael W., August, Keith J., Myers, G. Doug, Tam, Constantine S., Jaeger, Ulrich, Foley, Stephen Ronan, Borchmann, Peter, Schuster, Stephen J., Waller, Edmund K., Awasthi, Rakesh, Potthoff, Bernd, Warren, Andy, Waldron, Edward R., McBlane, Fraser, Chassot-Agostinho, Andrea and Laetsch, Theodore W. (2021). Tisagenlecleucel immunogenicity in relapsed/refractory acute lymphoblastic leukemia and diffuse large B-cell lymphoma. Blood Adv., 5 (23). S. 4980 - 4992. AMSTERDAM: ELSEVIER. ISSN 2473-9537
Rogasch, Julian M. M., Boellaard, Ronald, Pike, Lucy ORCID: 0000-0002-4381-3349, Borchmann, Peter, Johnson, Peter ORCID: 0000-0003-2306-4974, Wolf, Jurgen, Barrington, Sally F. and Kobe, Carsten (2021). Moving the goalposts while scoring-the dilemma posed by new PET technologies. Eur. J. Nucl. Med. Mol. Imaging, 48 (9). S. 2696 - 2711. NEW YORK: SPRINGER. ISSN 1619-7089
Rosenbrock, Johannes, Vasquez-Torres, Andres, Mueller, Horst, Behringer, Karolin, Zerth, Matthias, Celik, Eren, Fan, Jiaqi, Trommer, Maike, Linde, Philipp, Fuchs, Michael, Borchmann, Peter, Engert, Andreas, Marnitz, Simone and Baues, Christian (2021). Involved Site Radiotherapy Extends Time to Premature Menopause in Infra-Diaphragmatic Female Hodgkin Lymphoma Patients - An Analysis of GHSG HD14-and HD17-Patients. Front. Oncol., 11. LAUSANNE: FRONTIERS MEDIA SA. ISSN 2234-943X
Schuster, Stephen J., Tam, Constantine S., Borchmann, Peter, Worel, Nina, McGuirk, Joseph P., Holte, Harald, Waller, Edmund K., Jaglowski, Samantha, Bishop, Michael R., Damon, Lloyd E., Foley, Stephen Ronan, Westin, Jason R., Fleury, Isabelle, Ho, P. Joy, Mielke, Stephan ORCID: 0000-0002-8325-9215, Teshima, Takanori, Janakiram, Murali, Hsu, Jing-Mei, Izutsu, Koji, Kersten, Marie Jose, Ghosh, Monalisa, Wagner-Johnston, Nina, Kato, Koji, Corradini, Paolo, Martinez-Prieto, Marcela, Han, Xia, Tiwari, Ranjan, Salles, Gilles and Maziarz, Richard T. (2021). Long-term clinical outcomes of tisagenlecleucel in patients with relapsed or refractory aggressive B-cell lymphomas (JULIET): a multicentre, open-label, single-arm, phase 2 study. Lancet Oncol., 22 (10). S. 1403 - 1416. NEW YORK: ELSEVIER SCIENCE INC. ISSN 1474-5488
Sieg, Noelle, Naendrup, Jan-Hendrik, Goedel, Philipp, Balke-Want, Hyatt, Simon, Florian, Deckert, Martina, Gillessen, Sarah, Kreissl, Stefanie, Broeckelmann, Paul J., Borchmann, Peter, von Tresckow, Bastian and Heger, Jan-Michel (2021). Treatment patterns and disease course of previously untreated Primary Central Nervous System Lymphoma: Feasibility of MTX-based regimens in clinical routine. Eur. J. Haematol., 107 (2). S. 202 - 211. HOBOKEN: WILEY. ISSN 1600-0609
Voltin, Conrad-Amadeus ORCID: 0000-0002-5437-3959, Mettler, Jasmin, van Heek, Lutz, Goergen, Helen, Mueller, Horst, Baues, Christian, Keller, Ulrich, Meissner, Julia, Trautmann-Grill, Karolin, Kerkhoff, Andrea, Fuchs, Michael, Sasse, Stephanie, von Tresckow, Bastian, Dietlein, Markus, Borchmann, Peter, Engert, Andreas, Kobe, Carsten and Broeckelmann, Paul J. (2021). Early Response to First-Line Anti-PD-1 Treatment in Hodgkin Lymphoma: A PET-Based Analysis from the Prospective, Randomized Phase II NIVAHL Trial. Clin. Cancer Res., 27 (2). S. 402 - 408. PHILADELPHIA: AMER ASSOC CANCER RESEARCH. ISSN 1557-3265
2020
Awasthi, Rakesh, Pacaud, Lida, Waldron, Edward, Tam, Constantine S., Jager, Ulrich, Borchmann, Peter, Jaglowski, Samantha ORCID: 0000-0002-4335-2554, Foley, Stephen Ronan, van Besien, Koen ORCID: 0000-0002-8164-6211, Wagner-Johnston, Nina D., Kersten, Marie Jose, Schuster, Stephen J., Salles, Gilles, Maziarz, Richard T., Anak, Ozlem, del Corral, Christopher, Chu, Jufen, Gershgorin, Irina, Pruteanu-Malinici, Iulian, Chakraborty, Abhijit, Mueller, Karen Thudium and Waller, Edmund K. (2020). Tisagenlecleucel cellular kinetics, dose, and immunogenicity in relation to clinical factors in relapsed/refractory DLBCL. Blood Adv., 4 (3). S. 560 - 573. WASHINGTON: AMER SOC HEMATOLOGY. ISSN 2473-9537
Broeckelmann, Paul J., Borchmann, Sven, Borchmann, Peter and Engert, Andreas (2020). Steering Chimeric Antigen Receptor T Cells Into the Hodgkin Lymphoma Niche. J. Clin. Oncol., 38 (32). S. 3816 - 3820. ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. ISSN 1527-7755
Broeckelmann, Paul J., Goergen, Helen, Keller, Ulrich, Meissner, Julia, Ordemann, Rainer, Halbsguth, Teresa V., Sasse, Stephanie, Soekler, Martin, Kerkhoff, Andrea, Mathas, Stephan, Huettmann, Andreas, Bormann, Matthias, Zimmermann, Andreas, Mettler, Jasmin, Fuchs, Michael, von Tresckow, Bastian, Baues, Christian, Rosenwald, Andreas, Klapper, Wolfram, Kobe, Carsten, Borchmann, Peter and Engert, Andreas (2020). Efficacy of Nivolumab and AVD in Early-Stage Unfavorable Classic Hodgkin Lymphoma The Randomized Phase 2 German Hodgkin Study Group NIVAHL Trial. JAMA Oncol., 6 (6). S. 872 - 881. CHICAGO: AMER MEDICAL ASSOC. ISSN 2374-2445
Eichenauer, Dennis A., Pluetschow, Annette, Fuchs, Michael, Hartmann, Sylvia, Hansmann, Martin-Leo, Boell, Boris, von Tresckow, Bastian, Borchmann, Peter and Engert, Andreas (2020). Rituximab in newly diagnosed stage IA nodular lymphocyte-predominant Hodgkin lymphoma: long-term follow-up of a phase 2 study from the German Hodgkin Study Group. Leukemia, 34 (3). S. 953 - 957. LONDON: SPRINGERNATURE. ISSN 1476-5551
Eichenauer, Dennis A., Pluetschow, Annette, Fuchs, Michael, Sasse, Stephanie, Baues, Christian, Boell, Boris, von Tresckow, Bastian, Diehl, Volker, Borchmann, Peter and Engert, Andreas (2020). Long-Term Follow-Up of Patients With Nodular Lymphocyte-Predominant Hodgkin Lymphoma Treated in the HD7 to HD15 Trials: A Report From the German Hodgkin Study Group. J. Clin. Oncol., 38 (7). S. 698 - 707. ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. ISSN 1527-7755
Fuchs, Michael, Goergen, Helen, Kobe, Carsten, Borchmann, Peter and Engert, Andreas (2020). Inability of Fluorodeoxyglucose Positron Emission Tomography to Detect Viable Hodgkin Lymphoma During and After Treatment Reply. J. Clin. Oncol., 38 (10). S. 1116 - 1119. ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. ISSN 1527-7755
Held, Gerhard, Thurner, Lorenz, Poeschel, Viola, Berdel, Christian, Ott, German, Schmidt, Christian, Viardot, Andreas, Borchmann, Peter, Shpilberg, Ofer, Nickelsen, Maike, Federico, Massimo, Brown, Peter de Nully, Murawski, Niels, Trumper, Lorenz H., Schmidberger, Heinz, Ruebe, Christian, Fleckenstein, Jochen, Schmitz, Norbert, Loeffler, Markus, Ziepert, Marita and Alliance, German Lymphoma (2020). Role of radiotherapy and dose-densification of R-CHOP in primary mediastinal B-cell lymphoma: A subgroup analysis of the unfolder trial of the German Lymphoma Alliance (GLA). J. Clin. Oncol., 38 (15). ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. ISSN 1527-7755
Hokland, Peter ORCID: 0000-0002-1177-9756, Shah, Mansi, David, Kevin, Evens, Andrew, Auer, Rebecca, Ledieu, Rifca, Kreissl, Stefanie, Broeckelmann, Paul J., Borchmann, Peter, Korula, Anu, Mathews, Vikram, Owattanapanich, Weerapat and Trotman, Judith (2020). How I treat advanced Hodgkin lymphoma - a global view. Br. J. Haematol., 190 (6). S. 837 - 851. HOBOKEN: WILEY. ISSN 1365-2141
Holtick, Udo, Juehling, Anja, Goedel, Philipp, Balke-Want, Hyatt, Kutsch, Nadine, Aylikci, Oezlem, Wilhelm, Linda, Birkholz, Hanna, Scheid, Christof and Borchmann, Peter (2020). Effectiveness of Autologous Leukapheresis Collections for CAR T-cell Manufacturing in Patients with B-cell Malignancies. Bone Marrow Transplant., 55 (SUPPL 1). S. 255 - 256. LONDON: SPRINGERNATURE. ISSN 1476-5365
Kreissl, Stefanie, Mueller, Horst, Goergen, Helen, Meissner, Julia, Topp, Max, Soekler, Martin, Markova, Jana, Bernhard, Jurg, Greil, Richard, von Tresckow, Bastian, Behringer, Karolin, Rueffer, Jens-Ulrich, Flechtner, Hans-Henning, Moestl, Michaela, Fuchs, Michael, Engert, Andreas, Diehl, Volker and Borchmann, Peter (2020). Health-Related Quality of Life in Patients With Hodgkin Lymphoma: A Longitudinal Analysis of the German Hodgkin Study Group. J. Clin. Oncol., 38 (25). S. 2839 - 2857. ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. ISSN 1527-7755
Maziarz, Richard T., Waller, Edmund K. ORCID: 0000-0003-0816-6729, Jaeger, Ulrich, Fleury, Isabelle, McGuirk, Joseph, Holte, Harald ORCID: 0000-0001-9799-9428, Jaglowski, Samantha ORCID: 0000-0002-4335-2554, Schuster, Stephen J., Bishop, Michael R., Westin, Jason R., Mielke, Stephan ORCID: 0000-0002-8325-9215, Teshima, Takanori, Bachanova, Veronika, Foley, Stephen R., Borchmann, Peter, Salles, Gilles A., Zhang, Jie, Tiwari, Ranjan, Pacaud, Lida B., Ma, Qiufei and Tam, Constantine S. (2020). Patient-reported long-term quality of life after tisagenlecleucel in relapsed/refractory diffuse large B-cell lymphoma. Blood Adv., 4 (4). S. 629 - 638. WASHINGTON: AMER SOC HEMATOLOGY. ISSN 2473-9537
Montesinos-Rongen, Manuel, Brunn, Anna, Tuchscherer, Armin, Borchmann, Peter, Schorb, Elisabeth, Kasenda, Benjamin, Altmueller, Janine, Illerhaus, Gerald, Ruge, Maximilian, I, Maarouf, Mohammad, Buettner, Reinhard, Hansmann, Martin-Leo, Hallek, Michael, Prinz, Marco, Siebert, Reiner and Deckert, Martina (2020). Analysis of Driver Mutational Hot Spots in Blood-Derived Cell-Free DNA of Patients with Primary Central Nervous System Lymphoma Obtained before Intracerebral Biopsy. J. Mol. Diagn., 22 (10). S. 1300 - 1308. NEW YORK: ELSEVIER SCIENCE INC. ISSN 1943-7811
Reinke, Sarah, Broeckelmann, Paul J., Iaccarino, Ingram, Garcia-Marquez, Maria, Borchmann, Sven, Jochims, Franziska, Kotrova, Michaela ORCID: 0000-0001-5394-1072, Pal, Karol, Brueggemann, Monika, Hartmann, Elena, Sasse, Stephanie, Kobe, Carsten, Mathas, Stephan, Soekler, Martin, Keller, Ulrich, Bormann, Matthias, Zimmermann, Andreas, Richter, Julia, Fuchs, Michael, von Tresckow, Bastian, Borchmann, Peter, Schloesser, Hans, von Bergwelt-Baildon, Michael, Rosenwald, Andreas, Engert, Andreas and Klapper, Wolfram (2020). Tumor and microenvironment response but no cytotoxic T-cell activation in classic Hodgkin lymphoma treated with anti-PD1. Blood, 136 (25). S. 2851 - 2864. WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020
Relecom, Allan, Federico, Massimo, Connors, Joseph M., Coiffier, Bertrand, Biasoli, Irene ORCID: 0000-0001-7265-7691, Moccia, Alden ORCID: 0000-0001-8816-5464, Salles, Gilles, McKee, Thomas ORCID: 0000-0002-2147-3136, Miralbell, Raymond, Borchmann, Peter, Kuruvilla, John, Johnson, Peter ORCID: 0000-0003-2306-4974, Cavalli, Franco, Delavy, Martine, Dietrich, Pierre-Yves and Flahault, Antoine (2020). Resources-Stratified Guidelines for Classical Hodgkin Lymphoma. Int. J. Environ. Res. Public Health, 17 (5). BASEL: MDPI. ISSN 1660-4601
Stadtbaeumer, Nele ORCID: 0000-0002-2070-0157, Mueller, Horst, Goergen, Helen, Kreissl, Stefanie, Borchmann, Peter and Mayer, Axel ORCID: 0000-0001-9716-878X (2020). The Interplay Between Cancer-Related Fatigue and Functional Health in Hodgkin Lymphoma Survivors. Health Psychol., 39 (10). S. 905 - 912. WASHINGTON: AMER PSYCHOLOGICAL ASSOC. ISSN 1930-7810
Sureda, Anna, Andre, Marc, Borchmann, Peter, da Silva, Maria G., Gisselbrecht, Christian, Vassilakopoulos, Theodoros P., Zinzani, Pier Luigi and Walewski, Jan (2020). Improving outcomes after autologous transplantation in relapsed/refractory Hodgkin lymphoma: a European expert perspective. BMC Cancer, 20 (1). LONDON: BMC. ISSN 1471-2407
Voltin, Conrad-Amadeus ORCID: 0000-0002-5437-3959, Mettler, Jasmin, Grosse, Jirka, Dietlein, Markus, Baues, Christian, Schmitz, Christine, Borchmann, Peter, Kobe, Carsten and Hellwig, Dirk ORCID: 0000-0002-3056-0143 (2020). FDG-PET Imaging for Hodgkin and Diffuse Large B-Cell Lymphoma-An Updated Overview. Cancers, 12 (3). BASEL: MDPI. ISSN 2072-6694
Westin, Jason, Tam, Constantine, Borchmann, Peter, Jaeger, Ulrich, McGuirk, Joseph, Holte, Harald, Waller, Edmund, Jaglowski, Samantha, Bishop, Michael, Andreadis, Charalambos, Foley, Stephen Ronan, Fleury, Isabelle, Ho, P. Joy, Mielke, Stephan, Teshima, Takanori, Schuster, Stephen, Bachanova, Veronika, Maziarz, Richard, Van Besien, Koen, Izutsu, Koji, Kersten, Marie Jose, Magenau, John, Wagner-Johnston, Nina, Kato, Koji, Corradini, Paolo, Han, Xia, Tiwari, Ranjan, Agoulnik, Sergei, Elderjou, Lamis, Pacaud, Lida Bubuteishvili and Salles, Gilles (2020). Correlative Analyses of Patient and Clinical Characteristics Associated with Efficacy iN Tisagenlecleucel-Treated Relapsed/Refractory Diffuse Large B-Cell Lymphoma Patients in the Juliet Trial. Bone Marrow Transplant., 55 (SUPPL 1). S. 48 - 52. LONDON: SPRINGERNATURE. ISSN 1476-5365
2019
Bishop, Michael R., Maziarz, Richard T., Waller, Edmund K. ORCID: 0000-0003-0816-6729, Jaeger, Ulrich, Westin, Jason R., McGuirk, Joseph P., Fleury, Isabelle, Holte, Harald ORCID: 0000-0001-9799-9428, Borchmann, Peter, del Corral, Christopher, Tiwari, Ranjan, Anak, Oezlem, Awasthi, Rakesh, Pacaud, Lida, Romanov, Vadim V. and Schuster, Stephen J. (2019). Tisagenlecleucel in relapsed/refractory diffuse large B-cell lymphoma patients without measurable disease at infusion. Blood Adv., 3 (14). S. 2230 - 2237. WASHINGTON: AMER SOC HEMATOLOGY. ISSN 2473-9537
Boell, Boris, Pluetschow, Annette, Buerkle, Carolin, Atta, Johannes, Pfreundschuh, Michael, Feuring-Buske, Michaela, Vogelhuber, Martin, Soekler, Martin, Eichenauer, Dennis A., Thielen, Indra, von Tresckow, Bastian, Fuchs, Michael, Engert, Andreas and Borchmann, Peter (2019). Doxorubicin, vinblastine, dacarbazine and lenalidomide for older Hodgkin lymphoma patients: final results of a German Hodgkin Study Group (GHSG) phase-I trial. Br. J. Haematol., 185 (1). S. 42 - 53. HOBOKEN: WILEY. ISSN 1365-2141
Borchmann, Sven, Mueller, Horst, Haverkamp, Heinz ORCID: 0000-0001-6895-4132, Baues, Christian, Markova, Jana, Huettmann, Andreas, Glunz, Axel, Fuchs, Michael, Borchmann, Peter and Engert, Andreas (2019). Symptomatic osteonecrosis as a treatment complication in Hodgkin lymphoma: an analysis of the German Hodgkin Study Group (GHSG). Leukemia, 33 (2). S. 439 - 447. LONDON: NATURE PUBLISHING GROUP. ISSN 1476-5551
Fuchs, Michael, Goergen, Helen, Kobe, Carsten, Kuhnert, Georg, Lohri, Andreas, Greil, Richard, Sasse, Stephanie, Topp, Max S., Schaefer, Erhardt, Hertenstein, Bernd, Soekler, Martin, Vogelhuber, Martin, Zijlstra, Josee M., Keller, Ulrich Bernd, Krause, Stefan W., Wilhelm, Martin, Maschmeyer, Georg, Thiemer, Julia, Duehrsen, Ulrich, Meissner, Julia, Viardot, Andreas, Eich, Hans, Baues, Christian, Diehl, Volker, Rosenwald, Andreas, von Tresckow, Bastian, Dietlein, Markus, Borchmann, Peter and Engert, Andreas (2019). Positron Emission Tomography-Guided Treatment in Early-Stage Favorable Hodgkin Lymphoma: Final Results of the International, Randomized Phase III HD16 Trial by the German Hodgkin Study Group. J. Clin. Oncol., 37 (31). S. 2835 - 2847. ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. ISSN 1527-7755
Kreissl, Stefanie, Goergen, Helen, Mueller, Horst, Meissner, Julia, Mehnert, Anja, Buerkle, Carolin, Fuchs, Michael, Engert, Andreas, Behringer, Karolin and Borchmann, Peter (2019). Survivors' perspectives on risks and benefits of Hodgkin lymphoma treatment: results of a survey by the German Hodgkin Study Group. Leuk. Lymphoma, 60 (6). S. 1389 - 1399. ABINGDON: TAYLOR & FRANCIS LTD. ISSN 1029-2403
Mettler, Jasmin, Mueller, Horst, Voltin, Conrad-Amadeus ORCID: 0000-0002-5437-3959, Baues, Christian, Klaeser, Bernd, Moccia, Alden, Borchmann, Peter, Engert, Andreas, Kuhnert, Georg, Drzezga, Alexander, Dietlein, Markus and Kobe, Carsten (2019). Metabolic Tumor Volume for Response Prediction in Advanced-Stage Hodgkin Lymphoma. J. Nucl. Med., 60 (2). S. 207 - 212. RESTON: SOC NUCLEAR MEDICINE INC. ISSN 1535-5667
Poeschel, Viola, Held, Gerhard, Ziepert, Marita, Witzens-Harig, Mathias, Holte, Harald, Thurner, Lorenz, Borchmann, Peter, Viardot, Andreas, Soekler, Martin, Keller, Ulrich, Schmidt, Christian, Truemper, Lorenz, Mahlberg, Rolf, Marks, Reinhard, Hoeffkes, Heinz-Gert, Metzner, Bernd, Dierlamm, Judith, Frickhofen, Norbert, Haenel, Mathias, Neubauer, Andreas, Kneba, Michael, Merli, Francesco, Tucci, Alessandra ORCID: 0000-0003-3052-7463, Brown, Peter de Nully ORCID: 0000-0002-6522-4086, Federico, Massimo, Lengfelder, Eva, di Rocco, Alice, Trappe, Ralf ORCID: 0000-0001-7565-7160, Rosenwald, Andreas, Berdel, Christian, Maisenhoelder, Martin, Shpilberg, Ofer, Amam, Josif, Christofyllakis, Konstantinos ORCID: 0000-0002-0308-388X, Hartmann, Frank, Murawski, Niels, Stilgenbauer, Stephan, Nickelsen, Maike, Wulf, Gerald, Glass, Bertram, Schmitz, Norbert, Altmann, Bettina, Loeffler, Markus and Pfreundschuh, Michael (2019). Four versus six cycles of CHOP chemotherapy in combination with six applications of rituximab in patients with aggressive B-cell lymphoma with favourable prognosis (FLYER): a randomised, phase 3, non-inferiority trial. Lancet, 394 (10216). S. 2271 - 2282. NEW YORK: ELSEVIER SCIENCE INC. ISSN 1474-547X
Schuster, Stephen J., Bishop, Michael R., Tam, Constantine S., Waller, Edmund K., Borchmann, Peter, McGuirk, Joseph P., Jaeger, Ulrich, Jaglowski, Samantha, Andreadis, Charalambos, Westin, Jason R., Fleury, Isabelle, Bachanova, Veronika, Foley, S. Ronan, Ho, P. Joy p, Mielke, Stephan ORCID: 0000-0002-8325-9215, Magenau, John M., Holte, Harald, Pantano, Serafino, Pacaud, Lida B., Awasthi, Rakesh, Chu, Jufen, Anak, Ozlem, Salles, Gilles and Maziarz, Richard T. (2019). Tisagenlecleucel in Adult Relapsed or Refractory Diffuse Large B-Cell Lymphoma. N. Engl. J. Med., 380 (1). S. 45 - 57. WALTHAM: MASSACHUSETTS MEDICAL SOC. ISSN 1533-4406
Voltin, Conrad-Amadeus ORCID: 0000-0002-5437-3959, Mettler, Jasmin, Boellaard, Ronald ORCID: 0000-0002-0313-5686, Kuhnert, Georg, Dietlein, Markus, Borchmann, Peter, Drzezga, Alexander and Kobe, Carsten (2019). Quantitative assessment of F-18-FDG PET in patients with Hodgkin lymphoma: is it significantly affected by contrast-enhanced computed tomography attenuation correction? Nucl. Med. Commun., 40 (3). S. 249 - 258. PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS. ISSN 1473-5628
2018
Awasthi, Rakesh, Mueller, Karen Thudium, Yanik, Gregory A., Tam, Constantine Si Lun, Rives, Susana, McGuirk, Joseph, Boyer, Michael W., Jager, Ulrich, Baruchel, Andre, Myers, Gary Douglas, Borchmann, Peter, Jaglowski, Samantha Mary, Stefanski, Heather E., Bishop, Michael Russell, Waldron, Edward K., Hamilton, Jason, Cota, Mariana, Bubuteishvili-Pacaud, Lida and Waller, Edmund K. (2018). Considerations for tisagenlecleucel dosing rationale. J. Clin. Oncol., 36 (15). ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. ISSN 1527-7755
Balke-Want, Hyatt, Godel, Philipp, Abedpour, Nima, Peifer, Martin and Borchmann, Peter (2018). Clonal Evolution of a Mutation in PTPRA As a Potential Cause for Resistance Against Anti-CD19 Directed Chimeric Antigen Receptor T-Cell (CAR-T) Therapy with CTL019 in DLBCL Patients. Blood, 132. WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020
Boell, Boris, Fossa, Alexander, Goergen, Helen, Kamper, Peter, Leppa, Sirpa, Molin, Daniel, Meissner, Julia, Ritter, Ellen, Christensen, Jacob H., Hutchings, Martin ORCID: 0000-0003-3873-1741, Fuchs, Michael, Engert, Andreas, Kobe, Carsten and Borchmann, Peter (2018). B-CAP (brentuximab vedotin, cyclophosphamide, doxorubicin and predniso(lo)Ne) in Older Patients with Advanced-Stage Hodgkin Lymphoma: Results of a Phase II Intergroup Trial By the German Hodgkin Study Group (GHSG) and the Nordic Lymphoma Group (NLG). Blood, 132. WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020
Borchmann, Peter (2018). Lymphoma immunotherapy: Efficacy, safety, and accessibility to CAR-T therapy for lymphomas. Hemasphere, 2. S. 93 - 96. PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS. ISSN 2572-9241
Eichenauer, Dennis A., Pluetschow, Annette, Schroeder, Lena, Fuchs, Michael, Boell, Boris, von Tresckow, Bastian, Diehl, Volker, Borchmann, Peter and Engert, Andreas (2018). Relapsed and refractory nodular lymphocyte-predominant Hodgkin lymphoma: an analysis from the German Hodgkin Study Group. Blood, 132 (14). S. 1519 - 1526. WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020
Fuchs, Michael, Goergen, Helen, Kobe, Carsten, Eich, Hans, Baues, Christian, Greil, Richard, Sasse, Stephanie, Zijlstra, Josee M., Lohri, Andreas, Rosenwald, Andreas, von Tresckow, Bastian, Diehl, Volker, Kuhnert, Georg, Dietlein, Markus, Borchmann, Peter and Engert, Andreas (2018). PET-Guided Treatment of Early-Stage Favorable Hodgkin Lymphoma: Final Results of the International, Randomized Phase 3 Trial HD16 By the German Hodgkin Study Group. Blood, 132. WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020
Kobe, Carsten, Baues, Christian, Fuchs, Michael, Drzezga, Alexander, Borchmann, Peter and Dietlein, Markus (2018). Positron emission tomography in Hodgkin's lymphoma. Onkologe, 24 (4). S. 287 - 295. HEIDELBERG: SPRINGER HEIDELBERG. ISSN 1433-0415
Kobe, Carsten, Goergen, Helen, Baues, Christian, Kuhnert, Georg, Voltin, Conrad-Amadeus ORCID: 0000-0002-5437-3959, Zijlstra, Josee, Hoekstra, Otto, Mettler, Jasmin, Drzezga, Alexander, Engert, Andreas, Borchmann, Peter and Dietlein, Markus (2018). Outcome-based interpretation of early interim PET in advanced-stage Hodgkin lymphoma. Blood, 132 (21). S. 2273 - 2280. WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020
Maziarz, Richard T., Bishop, Michael R., Tam, Constantine S., Borchmann, Peter, Jaeger, Ulrich, McGuirk, Joseph, Waller, Edmund K., Jaglowski, Samantha, Andreadis, Charalambos, Foley, Stephen Ronan, Fleury, Isabelle, Mielke, Stephan, Westin, Jason R., Ho, Phoebe Joy, Bachanova, Veronika, Holte, Harald, Magenau, John M., Anak, Oezlem, Pacaud, Lida Bubuteishvili, Guenther, Siegbert, Zhang, Jie, Rasouliyan, Lawrence, Tai, Feng, Salles, Gilles A. and Schuster, Stephen J. (2018). Patient-Reported Quality of Life (QoL) Following Tisagenlecleucel Infusion in Adult Patients with Relapsed/Refractory (r/r) Diffuse Large B-Cell Lymphoma (DLBCL). Bone Marrow Transplant., 53. S. 177 - 179. LONDON: NATURE PUBLISHING GROUP. ISSN 1476-5365
Mueller, Karen Thudium, Grupp, Stephan A., Maude, Shannon L., Levine, John E., Pulsipher, Michael, Boyer, Michael W., August, Keith Jason, Myers, Gary Douglas, Awasthi, Rakesh, Waldron, Edward K., Bubuteishvili-Pacaud, Lida, Taran, Tanya, Cota, Mariana, Tam, Constantine Si Lun, Jager, Ulrich, Foley, Ronan, Borchmann, Peter, Schuster, Stephen J., Waller, Edmund K. and Laetsch, Theodore Willis (2018). Immunogenicity of tisagenlecleucel in relapsed/ refractory (R/R) B-cell acute lymphoblastic leukemia (B-ALL) and diffuse large B-cell lymphoma (DLBCL) patients. J. Clin. Oncol., 36 (15). ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. ISSN 1527-7755
Pfreundschuh, Michael, Murawski, Niels, Ziepert, Marita, Altmann, Bettina, Dreyling, Martin H., Borchmann, Peter, Luminari, Stefano, Witzens-Harig, Mathias, Dierlamm, Judith, Haenel, Mathias, Truemper, Lorenz, Metzner, Bernd, Lengfelder, Eva, Keller, Ulrich B., Ruebe, Christian, Berdel, Christian, Schmitz, Norbert, Held, Gerhard and Poeschel, Viola (2018). Radiotherapy (RT) to bulky (B) and extralymphatic (E) disease in combination with 6xR-CHOP-14 or R-CHOP-21 in young good-prognosis DLBCL patients: Results of the 2x2 randomized UNFOLDER trial of the DSHNHL/GLA. J. Clin. Oncol., 36 (15). ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. ISSN 1527-7755
Poeschel, Viola, Held, Gerhard, Ziepert, Marita, Altmann, Bettina, Witzens-Harig, Mathias, Holte, Harald, Thurner, Lorenz, Viardot, Andreas, Borchmann, Peter, Kanz, Lothar, Keller, Ulrich, Schmidt, Christian, Mahlberg, Rolf, Metzner, Bernd, Marks, Reinhard, Hoeffkes, Heinz-Gert, Christofyllakis, Konstantinos, Amam, Josif, Berdel, Christian, Stilgenbauer, Stephan, Schmitz, Norbert, Truemper, Lorenz, Murawski, Niels, Loeffler, Markus and Pfreundschuh, Michael (2018). Excellent Outcome of Young Patients (18-60 years) with Favourable-Prognosis Diffuse Large B-Cell Lymphoma (DLBCL) Treated with 4 Cycles CHOP Plus 6 Applications of Rituximab: Results of the 592 Patients of the Flyer Trial of the Dshnhl/GLA. Blood, 132. WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020
Rueffer, Jens Ulrich, Flechtner, Hans Henning and Borchmann, Peter (2018). Psychosocial stress and quality of life of long-term survivors of HodgkinE1/4s disease: No end of collation, but no initiation of patient-centered intervention? Onkologe, 24 (4). S. 335 - 340. NEW YORK: SPRINGER. ISSN 1433-0415
Sasse, Stephanie, Goergen, Helen, Pluetschow, Annette, Boell, Boris, Eichenauer, Dennis A., Fuchs, Michael, Behringer, Karolin, Zijlstra, Josee M., Greil, Richard, Markova, Jana, Topp, Max S., Meissner, Julia, Neubauer, Andreas, Baues, Christian, Engert, Andreas, Borchmann, Peter and von Tresckow, Bastian (2018). Outcome of Patients With Early-Stage Infradiaphragmatic Hodgkin Lymphoma: A Comprehensive Analysis From the German Hodgkin Study Group. J. Clin. Oncol., 36 (25). S. 2603 - 2621. ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. ISSN 1527-7755
Schuster, Stephen J., Bishop, Michael R., Tam, Constantine, Borchmann, Peter, Jaeger, Ulrich, Waller, Edmund K., Holte, Harald, McGuirk, Joseph P., Jaglowski, Samantha, Tobinai, Kensei, Andreadis, Charalambos, Fleury, Isabelle, Mielke, Stephan, Teshima, Takanori, Westin, Jason R., Bachanova, Veronika, Foley, Stephen Ronan, Ho, P. Joy, Magenau, John M., Wagner-Johnston, Nina D., Kato, Koji, Kersten, Marie Jose, Van Besien, Koen, Chu, Jufen, Jary, Aline, Anak, Ozlem, Salles, Gilles and Maziarz, Richard Thomas T. (2018). Sustained Disease Control for Adult Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma: An Updated Analysis of Juliet, a Global Pivotal Phase 2 Trial of Tisagenlecleucel. Blood, 132. WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020
von Tresckow, Bastian, Huettmann, Andreas, Vucinic, Vladan, Mueller, Horst, Pluetschow, Annette, Viardot, Andreas, Topp, Max S., Kobe, Carsten, Boell, Boris, Eichenauer, Dennis A., Sasse, Stephanie, Haverkamp, Heinz, Fuchs, Michael, Engert, Andreas and Borchmann, Peter (2018). Induction Therapy with Everolimus in Combination with DHAP (Dexamethasone, High-Dose AraC, Cisplatinum) in Patients with Relapsed or Refractory Classical Hodgkin Lymphoma: A Randomized, Placebo-Controlled Phase I/II Trial (HD-R3i). Blood, 132. WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020
von Tresckow, Bastian, Kreissl, Stefanie, Goergen, Helen, Brockelmann, Paul J., Pabst, Thomas, Fridrik, Michael, Rummel, Mathias, Jung, Wolfram, Thiemer, Julia, Sasse, Stephanie, Burkle, Carolin, Baues, Christian, Diehl, Volker, Engert, Andreas and Borchmann, Peter (2018). Intensive treatment strategies in advanced-stage Hodgkin's lymphoma (HD9 and HD12): analysis of long-term survival in two randomised trials. Lancet Haematol., 5 (10). S. E462 - 12. OXFORD: ELSEVIER SCI LTD. ISSN 2352-3026
2017
Borchmann, Peter and Engert, Andreas (2017). How Relevant Is Treatment-Related Infertility for Individual Treatment Selection in Hodgkin Lymphoma? Reply. J. Clin. Oncol., 35 (3). S. 375 - 378. ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. ISSN 1527-7755
Borchmann, Peter, Goergen, Helen, Kobe, Carsten, Lohri, Andreas, Greil, Richard, Eichenauer, Dennis A., Zijlstra, Josee M., Markova, Jana, Meissner, Julia, Feuring-Buske, Michaela, Huttmann, Andreas ORCID: 0000-0003-2230-3873, Dierlamm, Judith, Soekler, Martin, Beck, Hans-Joachim, Willenbacher, Wolfgang, Ludwig, Wolf-Dieter, Pabst, Thomas, Topp, Max S., Hitz, Felicitas, Bentz, Martin, Keller, Ulrich Bernd, Kuhnhardt, Dagmar, Ostermann, Helmut, Schmitz, Norbert, Hertenstein, Bernd, Aulitzky, Walter, Maschmeyer, Georg, Vieler, Tom, Eich, Hans, Baues, Christian, Stein, Harald, Fuchs, Michael, Kuhnert, Georg, Diehl, Volker, Dietlein, Markus and Engert, Andreas (2017). PET-guided treatment in patients with advanced-stage Hodgkin's lymphoma (HD18): final results of an open-label, international, randomised phase 3 trial by the German Hodgkin Study Group. Lancet, 390 (10114). S. 2790 - 2803. NEW YORK: ELSEVIER SCIENCE INC. ISSN 1474-547X
Borchmann, Peter, Haverkamp, Heinz ORCID: 0000-0001-6895-4132, Lohri, Andreas, Mey, Ulrich, Kreissl, Stefanie, Greil, Richard, Markova, Jana, Feuring-Buske, Michaela, Meissner, Julia, Duehrsen, Ulrich, Ostermann, Helmut, Keller, Ulrich, Maschmeyer, Georg, Kuhnert, Georg, Dietlein, Markus, Kobe, Carsten, Eich, Hans, Baues, Christian, Stein, Harald, Fuchs, Michael, Diehl, Volker and Engert, Andreas (2017). Progression-free survival of early interim PET-positive patients with advanced stage Hodgkin's lymphoma treated with BEACOPP(escalated) alone or in combination with rituximab (HD18): an open-label, international, randomised phase 3 study by the German Hodgkin Study Group. Lancet Oncol., 18 (4). S. 454 - 464. NEW YORK: ELSEVIER SCIENCE INC. ISSN 1474-5488
Broeckelmann, Paul J., Goergen, Helen, Kohnhorst, Charlotte, Von Tresckow, Bastian, Moccia, Alden, Markova, Jana, Meissner, Julia, Kerkhoff, Andrea, Ludwig, Wolf-Dieter, Fuchs, Michael, Borchmann, Peter and Engert, Andreas (2017). Late Relapse of Classical Hodgkin Lymphoma: An Analysis of the German Hodgkin Study Group HD7 to HD12 Trials. J. Clin. Oncol., 35 (13). S. 1444 - 1455. ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. ISSN 1527-7755
Eichenauer, Dennis A., Pluetschow, Annette, Kreissl, Stefanie, Soekler, Martin, Hellmuth, Johannes C. ORCID: 0000-0001-8409-3037, Meissner, Julia, Mathas, Stephan, Topp, Max S., Behringer, Karolin, Klapper, Wolfram, Kuhnert, Georg, Dietlein, Markus, Kobe, Carsten, Fuchs, Michael, Diehl, Volker, Engert, Andreas and Borchmann, Peter (2017). Incorporation of brentuximab vedotin into first-line treatment of advanced classical Hodgkin's lymphoma: final analysis of a phase 2 randomised trial by the German Hodgkin Study Group. Lancet Oncol., 18 (12). S. 1680 - 1688. NEW YORK: ELSEVIER SCIENCE INC. ISSN 1474-5488
Kobe, Carsten, Voltin, Conrad-Amadeus, Baues, Christian, Fuchs, Michael, Dietlein, Markus, Engert, Andreas, Borchmann, Peter and Drzezga, Alexander (2017). Staging Hodgkin Lymphoma Using PET - Can We Safely Exclude Bone Marrow Involvement? J. Nucl. Med., 58. RESTON: SOC NUCLEAR MEDICINE INC. ISSN 1535-5667
Lock, Dominik, Mockel-Tenbrinck, Nadine, Drechsel, Katharina, Barth, Carola, Mauer, Daniela, Schaser, Thomas, Kolbe, Carolin, Al Rawashdeh, Wael, Brauner, Janina, Hardt, Olaf, Pflug, Natali, Holtick, Udo, Borchmann, Peter, Assenmacher, Mario and Kaiser, Andrew (2017). Automated Manufacturing of Potent CD20-Directed Chimeric Antigen Receptor T Cells for Clinical Use. Hum. Gene Ther., 28 (10). S. 914 - 926. NEW ROCHELLE: MARY ANN LIEBERT, INC. ISSN 1557-7422
Loebel, Madlen, Eckey, Maren, Sotzny, Franziska, Hahn, Elisabeth ORCID: 0000-0001-7168-1403, Bauer, Sandra, Grabowski, Patricia, Zerweck, Johannes, Holenya, Pavlo, Hanitsch, Leif G., Wittke, Kirsten, Borchmann, Peter, Rueffer, Jens-Ulrich, Hiepe, Falk, Ruprecht, Klemens, Behrends, Uta, Meindl, Carola, Volk, Hans-Dieter ORCID: 0000-0002-7743-6668, Reimer, Ulf and Scheibenbogen, Carmen (2017). Serological profiling of the EBV immune response in Chronic Fatigue Syndrome using a peptide microarray. PLoS One, 12 (6). SAN FRANCISCO: PUBLIC LIBRARY SCIENCE. ISSN 1932-6203
Sasse, Stephanie, Broeckelmann, Paul J., Goergen, Helen, Pluetschow, Annette, Mueller, Horst, Kreissl, Stefanie, Buerkle, Carolin, Borchmann, Sven, Fuchs, Michael, Borchmann, Peter, Diehl, Volker and Engert, Andreas (2017). Long-Term Follow-Up of Contemporary Treatment in Early-Stage Hodgkin Lymphoma: Updated Analyses of the German Hodgkin Study Group HD7, HD8, HD10, and HD11 Trials. J. Clin. Oncol., 35 (18). S. 1999 - 2009. ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. ISSN 1527-7755
Schuster, Stephen, Bishop, Michael R., Tam, Constantine, Waller, Edmund K., Borchmann, Peter, McGuirk, Joseph, Jaeger, Ulrich, Jaglowski, Samantha, Andreadis, Charalambos, Westin, Jason, Fleury, Isabelle, Bachanova, Veronika, Foley, Stephen Ronan, Ho, P. Joy, Mielke, Stephan, Magenau, John M., Holte, Harald, Anak, Oezlem, Pacaud, Lida, Awasthi, Rakesh, Tai, Feng, Salles, Gilles and Maziarz, Richard T. (2017). Global Pivotal Phase 2 Trial of the CD19-Targeted Therapy CTL019 In Adult Patients with Relapsed or Refractory (R/R) Diffuse Large B-Cell Lymphoma (DLBCL)-An Interim Analysis. Clin. Lymphoma Myeloma Leuk., 17. S. S373 - 2. DALLAS: CIG MEDIA GROUP, LP. ISSN 2152-2669
2016
Behringer, Karolin, Goergen, Helen, Mueller, Horst, Thielen, Indra, Brillant, Corinne, Kreissl, Stefanie, Halbsguth, Teresa Veronika, Meissner, Julia, Greil, Richard, Moosmann, Peter, Shonukan, Oluwatoyin, Rueffer, Jens Ulrich, Flechtner, Hans-Henning, Fuchs, Michael, Diehl, Volker, Engert, Andreas and Borchmann, Peter (2016). Cancer-Related Fatigue in Patients With and Survivors of Hodgkin Lymphoma: The Impact on Treatment Outcome and Social Reintegration. J. Clin. Oncol., 34 (36). S. 4329 - 4346. ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. ISSN 1527-7755
Boell, Boris, Goergen, Helen, Behringer, Karolin, Broeckelmann, Paul J., Hitz, Felicitas, Kerkhoff, Andrea, Greil, Richard, von Tresckow, Bastian, Eichenauer, Dennis A., Buerkle, Carolin, Borchmann, Sven, Fuchs, Michael, Diehl, Volker, Engert, Andreas and Borchmann, Peter (2016). Bleomycin in older early-stage favorable Hodgkin lymphoma patients: analysis of the German Hodgkin Study Group (GHSG) HD10 and HD13 trials. Blood, 127 (18). S. 2189 - 2193. WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020
Borchmann, Peter and Engert, Andreas (2016). Balancing the Risk-Benefit Ratio in the Treatment of Patients With Advanced-Stage Hodgkin Lymphoma. J. Clin. Oncol., 34 (17). S. 1975 - 1979. ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. ISSN 1527-7755
Borchmann, Sven, Hude, Ida, Muller, Horst, Haverkamp, Heinz, Burkle, Carolin, Fuchs, Michael, Borchmann, Peter and Engert, Andreas (2016). Thrombosis in Hodgkin Lymphoma Patients: Incidence, Time Points, Risk Factors and Impact of Stage and Treatment. Blood, 128 (22). WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020
Broeckelmann, Paul J., Borchmann, Peter and Engert, Andreas (2016). Current and future immunotherapeutic approaches in Hodgkin lymphoma. Leuk. Lymphoma, 57 (9). S. 2014 - 2025. ABINGDON: TAYLOR & FRANCIS LTD. ISSN 1029-2403
Buerkle, Carolin and Borchmann, Peter (2016). Diagnosis and treatment of Hodgkin lymphoma. Onkologe, 22 (8). S. 603 - 617. NEW YORK: SPRINGER. ISSN 1433-0415
Eichenauer, Dennis A., Pluetschow, Annette, Schroeder, Lena, Fuchs, Michael, von Tresckow, Bastian, Diehl, Volker, Borchmann, Peter and Engert, Andreas (2016). Relapsed Nodular Lymphocyte-Predominant Hodgkin Lymphoma: An Analysis from the German Hodgkin Study Group (GHSG). Blood, 128 (22). WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020
Engert, Andreas, Balduini, Carlo, Brand, Anneke, Coiffier, Bertrand, Cordonnier, Catherine, Doehner, Hartmut, de Wit, Thom Duyvene, Eichinger, Sabine, Fibbe, Willem, Green, Tony, de Haas, Fleur, Iolascon, Achille, Jaffredo, Thierry, Rodeghiero, Francesco, Salles, Gilles, Schuringa, Jan Jacob, Andre, Marc, Andre-Schmutz, Isabelle ORCID: 0000-0002-3905-9910, Bacigalupo, Andrea, Bochud, Pierre-Yves ORCID: 0000-0002-2208-4757, den Boer, Monique ORCID: 0000-0002-5795-2921, Bonini, Chiara, Camaschella, Clara, Cant, Andrew, Cappellini, Maria Domenica, Cazzola, Mario, Lo Celso, Cristina, Dimopoulos, Meletios ORCID: 0000-0001-8990-3254, Douay, Luc, Dzierzak, Elaine ORCID: 0000-0001-8256-5635, Einsele, Hermann, Ferreri, Andres, De Franceschi, Lucia, Gaulard, Philippe, Gottgens, Berthold ORCID: 0000-0001-6302-5705, Greinacher, Andreas, Gresele, Paolo, Gribben, John, de Haan, Gerald ORCID: 0000-0001-9706-0138, Hansen, John-Bjarne, Hochhaus, Andreas ORCID: 0000-0003-0626-0834, Kadir, Rezan, Kaveri, Srini ORCID: 0000-0002-0837-4053, Kouskoff, Valerie, Kuehne, Thomas ORCID: 0000-0002-7387-7028, Kyrle, Paul, Ljungman, Per, Maschmeyer, Georg, Mendez-Ferrer, Simon ORCID: 0000-0002-9805-9988, Milsom, Michael, Mummery, Christine ORCID: 0000-0002-4549-6535, Ossenkoppele, Gert, Pecci, Alessandro ORCID: 0000-0001-9202-7013, Peyvandi, Flora ORCID: 0000-0001-7423-9864, Philipsen, Sjaak, Reitsma, Pieter, Maria Ribera, Jose, Risitano, Antonio, Rivella, Stefano ORCID: 0000-0002-0938-6558, Ruf, Wolfram, Schroeder, Timm ORCID: 0000-0001-9320-0252, Scully, Marie, Socie, Gerard, Staal, Frank, Stanworth, Simon, Stauder, Reinhard, Stilgenbauer, Stephan, Tamary, Hannah, Theilgaard-Monch, Kim, Thein, Swee Lay, Tilly, Herve, Trneny, Marek ORCID: 0000-0002-6952-6073, Vainchenker, William ORCID: 0000-0003-4705-202X, Vannucchi, Alessandro Maria, Viscoli, Claudio, Vrielink, Hans, Zaaijer, Hans, Zanella, Alberto, Zolla, Lello, Zwaginga, Jaap Jan, Martinez, Patricia Aguilar, van den Akker, Emile, Allard, Shubha, Anagnou, Nicholas, Andolfo, Immacolata ORCID: 0000-0003-0493-812X, Andrau, Jean-Christophe ORCID: 0000-0003-0203-8507, Angelucci, Emanuele ORCID: 0000-0002-6512-6080, Anstee, David, Aurer, Igor, Avet-Loiseau, Herve ORCID: 0000-0002-3050-0140, Aydinok, Yesim, Bakchoul, Tamam, Balduini, Alessandra, Barcellini, Wilma, Baruch, Dominique ORCID: 0000-0003-2835-5500, Baruchel, Andre, Bayry, Jagadeesh ORCID: 0000-0003-0498-9808, Bento, Celeste ORCID: 0000-0003-1080-411X, van den Berg, Anke ORCID: 0000-0002-8894-2638, Bernardi, Rosa, Bianchi, Paola ORCID: 0000-0001-5976-5233, Bigas, Anna ORCID: 0000-0003-4801-6899, Biondi, Andrea ORCID: 0000-0002-6757-6173, Bohonek, Milos, Bonnet, Dominique ORCID: 0000-0002-4735-5226, Borchmann, Peter, Borregaard, Niels, Braekkan, Sigrid ORCID: 0000-0002-9678-9696, van den Brink, Marcel, Brodin, Ellen, Bullinger, Lars, Buske, Christian, Butzeck, Barbara, Cammenga, Jorg, Campo, Elias ORCID: 0000-0001-9850-9793, Carbone, Antonino ORCID: 0000-0003-2211-639X, Cervantes, Francisco, Cesaro, Simone ORCID: 0000-0002-8698-9547, Charbord, Pierre, Claas, Frans, Cohen, Hannah, Conard, Jacqueline, Coppo, Paul, Vives Corrons, Joan-Lluis, da Costa, Lydie, Davi, Frederic, Delwel, Ruud, Dianzani, Irma, Domanovic, Dragoslav, Donnelly, Peter, Drnovsek, Tadeja Dovc, Dreyling, Martin, Du, Ming-Qing, Dufour, Carlo, Durand, Charles, Efremov, Dimitar ORCID: 0000-0001-9081-5462, Eleftheriou, Androulla, Elion, Jacques ORCID: 0000-0002-8407-1783, Emonts, Marieke, Engelhardt, Monika, Ezine, Sophie, Falkenburg, Fred, Favier, Remi, Federico, Massimo ORCID: 0000-0002-9889-3796, Fenaux, Pierre, Fitzgibbon, Jude, Flygare, Johan ORCID: 0000-0002-1962-5276, Foa, Robin, Forrester, Lesley, Galacteros, Frederic, Garagiola, Isabella, Gardiner, Chris ORCID: 0000-0002-2318-0062, Garraud, Olivier, van Geet, Christel, Geiger, Hartmut, Geissler, Jan, Germing, Ulrich, Ghevaert, Cedric, Girelli, Domenico ORCID: 0000-0001-9684-1899, Godeau, Bertrand, Goekbuget, Nicola, Goldschmidt, Hartmut, Goodeve, Anne, Graf, Thomas, Graziadei, Giovanna ORCID: 0000-0002-6801-5730, Griesshammer, Martin, Gruel, Yves, Guilhot, Francois ORCID: 0000-0001-7222-487X, von Gunten, Stephan ORCID: 0000-0002-2753-8738, Gyssens, Inge ORCID: 0000-0002-9226-0752, Halter, Jorg, Harrison, Claire, Harteveld, Cornelis, Hellstrom-Lindberg, Eva, Hermine, Olivier ORCID: 0000-0003-2574-3874, Higgs, Douglas ORCID: 0000-0003-3579-8705, Hillmen, Peter, Hirsch, Hans, Hoskin, Peter ORCID: 0000-0001-8323-9567, Huls, Gerwin, Inati, Adlette, Johnson, Peter, Kattamis, Antonis, Kiefel, Volker, Kleanthous, Marina, Klump, Hannes ORCID: 0000-0003-3536-1212, Krause, Daniela, Hovinga, Johanna Kremer, Lacaud, Georges, Lacroix-Desmazes, Sebastien ORCID: 0000-0001-5625-8447, Landman-Parker, Judith, LeGouill, Steven, Lenz, Georg, von Lilienfeld-Toal, Marie, von Lindern, Marieke ORCID: 0000-0001-6162-6320, Lopez-Guillermo, Armando, Lopriore, Enrico, Lozano, Miguel, MacIntyre, Elizabeth, Makris, Michael, Mannhalter, Christine, Martens, Joost ORCID: 0000-0003-2008-6537, Mathas, Stephan, Matzdorff, Axel, Medvinsky, Alexander, Menendez, Pablo, Migliaccio, Anna Rita, Miharada, Kenichi, Mikulska, Malgorzata, Minard, Veronique, Montalban, Carlos, de Montalembert, Mariane, Montserrat, Emili, Morange, Pierre-Emmanuel, Mountford, Joanne, Muckenthaler, Martina, Mueller-Tidow, Carsten, Mumford, Andrew, Nadel, Bertrand, Navarro, Jose-Tomas, el Nemer, Wassim, Noizat-Pirenne, France, O'Mahony, Brian, Oldenburg, Johannes, Olsson, Martin, Oostendorp, Robert, Palumbo, Antonio, Passamonti, Francesco ORCID: 0000-0001-8068-5289, Patient, Roger, de Latour, Regis Peffault, Pflumio, Francoise ORCID: 0000-0001-8995-596X, Pierelli, Luca ORCID: 0000-0002-1715-3914, Piga, Antonio, Pollard, Debra ORCID: 0000-0002-7797-3500, Raaijmakers, Marc, Radford, John, Rambach, Ralf, Rao, A. Koneti, Raslova, Hana ORCID: 0000-0001-8846-5299, Rebulla, Paolo ORCID: 0000-0002-3875-5754, Rees, David, Ribrag, Vincent, Rijneveld, Anita, Rinalducci, Sara, Robak, Tadeusz, Roberts, Irene, Rodrigues, Charlene ORCID: 0000-0003-0942-3707, Rosendaal, Frits, Rosenwald, Andreas, Rule, Simon, Russo, Roberta ORCID: 0000-0002-3624-7721, Saglio, Guiseppe, Sanchez, Mayka ORCID: 0000-0002-6499-5989, Scharf, Ruediger E., Schlenke, Peter, Semple, John, Sierra, Jorge, So-Osman, Cynthia, Manuel Soria, Jose, Stamatopoulos, Kostas, Stegmayr, Bernd, Stunnenberg, Henk, Swinkels, Dorine, Taborda Barata, Joao Pedro, Taghon, Tom, Taher, Ali, Terpos, Evangelos, Thachil, Jecko, Tissot, Jean Daniel ORCID: 0000-0003-2493-8469, Touw, Ivo, Toye, Ash, Trappe, Ralf ORCID: 0000-0001-7565-7160, Traverse-Glehen, Alexandra, Unal, Sule, Vaulont, Sophie, Viprakasit, Vip, Vitolo, Umberto, van Wijk, Richard, Wojtowicz, Agnieszka, Zeerleder, Sacha and Zieger, Barbara (2016). The European Hematology Association Roadmap for European Hematology Research: a consensus document. Haematologica, 101 (2). S. 115 - 209. PAVIA: FERRATA STORTI FOUNDATION. ISSN 0390-6078
Hess, Georg, Karola, Wagner, LaRosee, Paul, Keller, Ulrich, Atta, Johannes, Witzens-Harig, Mathias, Crombe, Anne, Medler, Christoph, Borchmann, Peter, Bitz, Ulrich, Lerchenmuller, Christian, Theobald, Matthias and Dreyling, Martin H. (2016). Temsirolimus in Combination with Bendamustine and Rituximab (BeRT) for the Treatment of Relapsed Mantle Cell and Follicular Lymphoma: Final Phase I/II Results. Blood, 128 (22). WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020
Kreissl, Stefanie, Mueller, Horst, Goergen, Helen, Mayer, Axel, Brillant, Corinne, Behringer, Karolin, Halbsguth, Teresa Veronika, Hitz, Felicitas, Soekler, Martin, Shonukan, Oluwatoyin, Rueffer, Jens Ulrich, Flechtner, Hans-Henning, Fuchs, Michael, Diehl, Volker, Engert, Andreas and Borchmann, Peter (2016). Cancer-related fatigue in patients with and survivors of Hodgkin's lymphoma: a longitudinal study of the German Hodgkin Study Group. Lancet Oncol., 17 (10). S. 1453 - 1463. NEW YORK: ELSEVIER SCIENCE INC. ISSN 1474-5488
Kreissl, Stefanie, von Tresckow, Bastian, Goergen, Helen, Haverkamp, Heinz, Sasse, Stephanie, Diehl, Volker, Engert, Andreas and Borchmann, Peter (2016). Beacoppescalated Followed By Radiotherapy of Initial Bulk or Residual Disease in Advanced Stage Hodgkin Lymphoma: Long-Term Follow up of the HD9 and HD12 Trials of the German Hodgkin Study Group. Blood, 128 (22). WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020
Sasse, Stephanie, Alram, Magdalena, Mueller, Horst, Smardova, Lenka, Metzner, Bernd, Doehner, Hartmut, Fischer, Thomas, Niederwieser, Dietger W., Schmitz, Norbert, Schaefer-Eckart, Kerstin, Raemaekers, John M. M., Schmalz, Oliver, Tresckow, Bastian V., Engert, Andreas and Borchmann, Peter (2016). Prognostic relevance of DHAP dose-density in relapsed Hodgkin lymphoma: an analysis of the German Hodgkin-Study Group. Leuk. Lymphoma, 57 (5). S. 1067 - 1074. ABINGDON: TAYLOR & FRANCIS LTD. ISSN 1029-2403
Sickinger, Marie T., von Tresckow, Bastian, Kobe, Carsten, Borchmann, Peter, Engert, Andreas and Skoetz, Nicole (2016). PET-adapted omission of radiotherapy in early stage Hodgkin lymphoma-a systematic review and meta-analysis. Crit. Rev. Oncol./Hematol., 101. S. 86 - 93. NEW YORK: ELSEVIER SCIENCE INC. ISSN 1879-0461
2015
Borchmann, Peter, Eichenauer, Dennis A., Pluetschow, Annette, Haverkamp, Heinz, Kreissl, Stefanie, Fuchs, Michael, Soekler, Martin, Hellmuth, Johannes C., Meissner, Julia, Mathas, Stephan, Behringer, Karolin, Dietlein, Markus, Kobe, Carsten, Diehl, Volker and Engert, Andreas (2015). Targeted Beacopp Variants in Patients with Newly Diagnosed Advanced Stage Classical Hodgkin Lymphoma: Final Analysis of a Randomized Phase II Study. Blood, 126 (23). WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020
Broeckelmann, Paul J., Goergen, Helen, Fuchs, Michael, Kriz, Jan, Semrau, Robert, Baues, Christian, Kobe, Carsten, Behringer, Karolin, Eichenauer, Dennis A., von Tresckow, Bastian, Klimm, Beate, Halbsguth, Teresa, Wongso, Diana, Pluetschow, Annette, Haverkamp, Heinz ORCID: 0000-0001-6895-4132, Dietlein, Markus, Eich, Hans T., Stein, Harald, Diehl, Volker, Borchmann, Peter and Engert, Andreas (2015). Impact of centralized diagnostic review on quality of initial staging in Hodgkin lymphoma: experience of the German Hodgkin Study Group. Br. J. Haematol., 171 (4). S. 547 - 557. HOBOKEN: WILEY. ISSN 1365-2141
Broeckelmann, Paul J., Mueller, Horst, Casasnovas, Olivier, Hutchings, Martin ORCID: 0000-0003-3873-1741, von Tresckow, Bastian, Borchmann, Peter, Moskowitz, Craig and Engert, Andreas (2015). Risk Factors and a Prognostic Score for Progression Free Survival after Treatment with Autologous Stem Cell Transplantation (ASCT) in Patients with Relapsed or Refractory Hodgkin Lymphoma (rrHL). Blood, 126 (23). WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020
Eichenauer, Dennis A., Goergen, Helen, Pluetschow, Annette, Behringer, Karolin, Kreissl, Stefanie, Broeckelmann, Paul, Fuchs, Michael, Boell, Boris, von Tresckow, Bastian, Borchmann, Peter and Engert, Andreas (2015). Phase II Study of Ofatumumab in Relapsed Nodular Lymphocyte-Predominant Hodgkin Lymphoma: A Report from the German Hodgkin Study Group. Blood, 126 (23). WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020
Eichenauer, Dennis A., Pluetschow, Annette, Fuchs, Michael, von Tresckow, Bastian, Boell, Boris, Behringer, Karolin, Diehl, Volker, Eich, Hans Theodor, Borchmann, Peter and Engert, Andreas (2015). Long-Term Course of Patients With Stage IA Nodular Lymphocyte-Predominant Hodgkin Lymphoma: A Report From the German Hodgkin Study Group. J. Clin. Oncol., 33 (26). S. 2857 - 2865. ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. ISSN 1527-7755
Haverkamp, Heinz ORCID: 0000-0001-6895-4132, Boell, Boris, Eichenauer, Dennis A., Sasse, Stephanie, Fuchs, Michael, Borchmann, Peter, Diehl, Volker, Engert, Andreas and von Tresckow, Bastian (2015). Impact of Bleomycin and Vincristine Dose Reductions in Patients With Advanced Hodgkin Lymphoma Treated With BEACOPP: An Analysis of the German Hodgkin Study Group HD12 and HD15 Trials. J. Clin. Oncol., 33 (22). S. 2430 - 2440. ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. ISSN 1527-7755
Kreissl, Stefanie, Goergen, Helen, von Tresckow, Bastian, Behringer, Karolin, Markova, Jana, Lohri, Andreas, Meissner, Julia, Zijlstra, Josee M., Greil, Richard, Topp, Max S., Soekler, Martin, Doehner, Hartmut, Diehl, Volker, Engert, Andreas and Borchmann, Peter (2015). Primary Progressive Disease in Hodgkin Lymphoma Patients: A Retrospective Analysis from the German Hodgkin Study Group. Blood, 126 (23). WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020
Rothe, Achim, Sasse, Stephanie, Topp, Max S., Eichenauer, Dennis A., Hummel, Horst, Reiners, Katrin S., Dietlein, Markus, Kuhnert, Georg, Kessler, Joerg, Buerkle, Carolin, Ravic, Miroslav, Knackmuss, Stefan, Marschner, Jens-Peter, von Strandmann, Elke Pogge, Borchmann, Peter and Engert, Andreas (2015). A phase 1 study of the bispecific anti-CD30/CD16A antibody construct AFM13 in patients with relapsed or refractory Hodgkin lymphoma. Blood, 125 (26). S. 4024 - 4032. WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020
Schmitz, Norbert, Nickelsen, Maike, Ziepert, Marita, Haenel, Mathias, Viardot, Andreas, Dreyling, Martin H., Borchmann, Peter, Bokemeyer, Carsten, Peschel, Christian, Wolf, Hans-Heinrich, Mahlberg, Rolf, Pfreundschuh, Michael and Glass, Bertram (2015). Optimization of Rituximab for Treatment of DLBCL in Young, High-Risk Patients-Results of the Dense-R-CHOEP Trial of the German High-Grade Lymphoma Study Group. Blood, 126 (23). WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020
Sickinger, Marie-Therese, von Tresckow, Bastian, Kobe, Carsten, Engert, Andreas, Borchmann, Peter and Skoetz, Nicole (2015). Positron emission tomography-adapted therapy for first-line treatment in individuals with Hodgkin lymphoma. Cochrane Database Syst Rev. (1). HOBOKEN: WILEY. ISSN 1361-6137
2014
Boell, Boris, Behringer, Karolin, Goergen, Helen, Broeckelmann, Paul, von Tresckow, Bastian, Eichenauer, Dennis A., Fuchs, Michael, Diehl, Volker, Engert, Andreas and Borchmann, Peter (2014). Doxorubicin, Vinblastine and Dacarbazine with or without Bleomycin for Older Patients with Early Stage Favorable Hodgkin Lymphoma: An Analysis of the German Hodgkin Study Group (GHSG) HD10 and HD13 Trials. Blood, 124 (21). WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020
Borchmann, Peter (2014). Early Intensification Treatment Approach in Advanced-stage Hodgkin Lymphoma. Hematol. Oncol. Clin. North Am., 28 (1). S. 65 - 76. PHILADELPHIA: W B SAUNDERS CO-ELSEVIER INC. ISSN 1558-1977
Borchmann, Peter, Haverkamp, Heinz, Lohri, Andreas, Kreissl, Stefanie, Greil, Richard, Markova, Jana, Feuring-Buske, Michaela, Meissner, Julia, Duehrsen, Ulrich, Engel, Nicole, Keller, Ulrich, Maschmeyer, Georg, Dietlein, Markus, Kobe, Carsten, Fuchs, Michael, Diehl, Volker and Engert, Andreas (2014). Addition of Rituximab to BEACOPP(escalated) to Improve the Outcome of Early Interim PET Positive Advanced Stage Hodgkin Lymphoma Patients: Second Planned Interim Analysis of the HD18 Study. Blood, 124 (21). WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020
Diehl, Volker and Borchmann, Peter (2014). Hodgkin Lymphoma Preface. Hematol. Oncol. Clin. North Am., 28 (1). S. IX - 2. PHILADELPHIA: W B SAUNDERS CO-ELSEVIER INC. ISSN 1558-1977
Eichenauer, Dennis A., Pluetschow, Annette, Fuchs, Michael, Behringer, Karolin, Boell, Boris, von Tresckow, Bastian, Diehl, Volker, Borchmann, Peter and Engert, Andreas (2014). Treatment of Stage IA Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL): An Analysis from the German Hodgkin Study Group (GHSG). Blood, 124 (21). WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020
Eichenauer, Dennis A., Thielen, Indra, Haverkamp, Heinz ORCID: 0000-0001-6895-4132, Franklin, Jeremy ORCID: 0000-0003-1536-0925, Behringer, Karolin, Halbsguth, Teresa, Klimm, Beate, Diehl, Volker, Sasse, Stephanie, Rothe, Achim, Fuchs, Michael, Boell, Boris, von Tresckow, Bastian, Borchmann, Peter and Engert, Andreas (2014). Therapy-related acute myeloid leukemia and myelodysplastic syndromes in patients with Hodgkin lymphoma: a report from the German Hodgkin Study Group. Blood, 123 (11). S. 1658 - 1665. WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020
Gisselbrecht, Christian, Borchmann, Peter, D'Amore, Francesco, Illidge, Timothy M. and Zinzani, Pier Luigi ORCID: 0000-0002-2112-2651 (2014). Challenging CD30-positive lymphomas - Current challenges, new insights and future directions: Joining a conversation on CD30+lymphomas. Leuk. Res., 38 (9). S. 1003 - 1004. OXFORD: PERGAMON-ELSEVIER SCIENCE LTD. ISSN 0145-2126
Kobe, Carsten, Kuhnert, Georg, Kahraman, Deniz, Haverkamp, Heinz ORCID: 0000-0001-6895-4132, Eich, Hans-Theodor, Franke, Mareike, Persigehl, Thorsten, Klutmann, Susanne, Amthauer, Holger, Bockisch, Andreas, Kluge, Regine, Wolf, Hans-Heinrich, Maintz, David, Fuchs, Michael, Borchmann, Peter, Diehl, Volker, Drzezga, Alexander, Engert, Andreas and Dietlein, Markus (2014). Assessment of Tumor Size Reduction Improves Outcome Prediction of Positron Emission Tomography/Computed Tomography After Chemotherapy in Advanced-Stage Hodgkin Lymphoma. J. Clin. Oncol., 32 (17). S. 1776 - 1782. ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. ISSN 1527-7755
Kreissl, Stefanie, Mueller, Horst, Mayer, Axel, Behringer, Karolin, Diehl, Volker, Engert, Andreas and Borchmann, Peter (2014). Fatigue in Hodgkin Lymphoma Patients: Longitudinal Evaluation and Curve Types up to 5 Years. Blood, 124 (21). WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020
Rancea, Michaela, Will, Andrea, Borchmann, Peter, Monsef, Ina, Engert, Andreas and Skoetz, Nicole ORCID: 0000-0003-4744-6192 (2014). Sixteenth Biannual Report of the Cochrane Haematological Malignancies Group: Focus on Non-Hodgkin's Lymphoma. JNCI-J. Natl. Cancer Inst., 106 (8). CARY: OXFORD UNIV PRESS INC. ISSN 1460-2105
Rothe, Achim, Jachimowicz, Ron D., Borchmann, Sven, Madlener, Marie, Kessler, Joerg, Reiners, Katrin S., Sauer, Maike, Hansen, Hinrich P., Ullrich, Roland T., Chatterjee, Sampurna, Borchmann, Peter, Yazaki, Paul, Koslowsky, Thomas C., Engert, Andreas, Heukamp, Lukas C., Hallek, Michael and von Strandmann, Elke Pogge (2014). The bispecific immunoligand ULBP2-aCEA redirects natural killer cells to tumor cells and reveals potent anti-tumor activity against colon carcinoma. Int. J. Cancer, 134 (12). S. 2829 - 2841. HOBOKEN: WILEY. ISSN 1097-0215
von Tresckow, Bastian, Mueller, Horst, Eichenauer, Dennis A., Glossmann, Jan P., Josting, Andreas, Boell, Boris, Klimm, Beate, Sasse, Stephanie, Fuchs, Michael, Borchmann, Peter and Engert, Andreas (2014). Outcome and risk factors of patients with Hodgkin Lymphoma who relapse or progress after autologous stem cell transplant. Leuk. Lymphoma, 55 (8). S. 1922 - 1925. LONDON: INFORMA HEALTHCARE. ISSN 1029-2403
von Tresckow, Bastian, Pluetschow, Annette, Haverkamp, Heinz, Vucinic, Vladan, Rank, Andreas, Topp, Max S., Feuring-Buske, Michaela, Kobe, Carsten, Kuhnert, Georg, Boell, Boris, Eichenauer, Dennis A., Sasse, Stephanie, Fuchs, Michael, Engert, Andreas and Borchmann, Peter (2014). A Phase I Study of Everolimus in Combination with Time-Intensified DHAP ( Dexamethasone, High-Dose AraC [Cytarabine], Cisplatinum) in Patients with Relapsed or Refractory Classical Hodgkin Lymphoma (cHL). Blood, 124 (21). WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020
2013
Boell, Boris, Goergen, Helen, Arndt, Nils, Meissner, Julia, Krause, Stefan W., Schnell, Roland, von Tresckow, Bastian, Eichenauer, Dennis A., Sasse, Stephanie, Fuchs, Michael, Behringer, Karalin, Klimm, Beate C., Naumann, Ralph, Diehl, Volker, Engert, Andreas and Borchmann, Peter (2013). Relapsed Hodgkin Lymphoma in Older Patients: A Comprehensive Analysis From the German Hodgkin Study Group. J. Clin. Oncol., 31 (35). S. 4431 - 4442. ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. ISSN 1527-7755
Borchmann, Peter, Skoetz, Nicole ORCID: 0000-0003-4744-6192 and Trelle, Sven ORCID: 0000-0002-8162-8910 (2013). BEACOPP or no BEACOPP? Reply. Lancet Oncol., 14 (12). S. E488 - 3. NEW YORK: ELSEVIER SCIENCE INC. ISSN 1474-5488
2012
Engert, Andreas, Kobe, Carsten, Haverkamp, Heinz, Kuhnert, Georg, Markova, Jana, Lohri, Andreas, Klutmann, Susanne, Amthauer, Holger, Diehl, Volker, Borchmann, Peter and Dietlein, Markus (2012). Relative Reduction of Residual Tumor Improves Outcome Prediction of PET After Effective Chemotherapy for Patients with Advanced Stage Hodgkin Lymphoma. Blood, 120 (21). WASHINGTON: AMER SOC HEMATOLOGY. ISSN 0006-4971
Herfarth, Klaus, Engelhard, Marianne, Borchmann, Peter, Hohloch, Karin, Budach, Volker, Viardot, Andreas, Witzens-Harig, Mathias, Eich, Hans, Hiddemann, Wolfgang and Dreyling, Martin (2012). Treatment of Early Stage Nodal Follicular Lymphoma Using Involved-Field Radiotherapy and Rituximab: Preliminary Results of the Mir Trial (phase II study of the German Low Grade Lymphoma Study Group (GLSG)). Blood, 120 (21). WASHINGTON: AMER SOC HEMATOLOGY. ISSN 0006-4971
Karuturi, Meghan S., Arai, Sally, Chen, Robert W., Gopal, Ajay K., Feng, Lei, Yuan, Ying, Smith, Scott E., Ansell, Stephen M., Rosenblatt, Joseph D., Savage, Kerry J., Ramchandren, Radhakrishnan, Bartlet, Nancy L., Cheson, Bruce D., Forero-Torres, Andres, Moskowitz, Craig H., Connors, Joseph M., Fanale, Michelle A., de Vos, Sven, Engert, Andreas, Illidge, Tim, Borchmann, Peter, Morschhauser, Franck, Horning, Sandra J. and Younes, Anas (2012). Overall Survival Benefit for Patients with Relapsed Hodgkin Lymphoma Treated with Brentuximab Vedotin After Autologous Stem Cell Transplant. Blood, 120 (21). WASHINGTON: AMER SOC HEMATOLOGY. ISSN 0006-4971
Klimm, Beate, Brillant, Corinne, Skoetz, Nicole ORCID: 0000-0003-4744-6192, Mueller, Horst, Engert, Andreas and Borchmann, Peter (2012). The Effect of Specialized Cancer Treatment Centers on Treatment Efficacy in Hodgkin's Lymphoma. Dtsch. Arztebl. Int., 109 (51-52). S. 893 - 900. COLOGNE: DEUTSCHER AERZTE-VERLAG GMBH. ISSN 1866-0452
Klimm, Beate, Goergen, Helen, Fuchs, Michael, von Tresckow, Bastian, Diehl, Volker, Eich, Hans Theodor, Engert, Andreas and Borchmann, Peter (2012). Discrimination of an Early Unfavorable Risk Group Has Significant Impact On Treatment Outcome in Early-Stage Hodgkin Lymphoma: An Analysis of International Staging Definitions and Risk Factors. Blood, 120 (21). WASHINGTON: AMER SOC HEMATOLOGY. ISSN 0006-4971
Rancea, Michaela, Engert, Andreas, Borchmann, Peter, von Tresckow, Bastian, Halbsguth, Teresa, Behringer, Karolin, Wongso, Diana, Boell, Boris, Klimm, Beate, Thielen, Indra, Eichenauer, Dennis A. and Skoetz, Nicole (2012). Interdisciplinary Evidence-Based Guideline for Diagnosis, Therapy and Follow-up of Adult Hodgkin Lymphoma Patients. Blood, 120 (21). WASHINGTON: AMER SOC HEMATOLOGY. ISSN 0006-4971
Schmitz, Norbert, Nickelsen, Maike, Ziepert, Marita, Haenel, Mathias, Borchmann, Peter, Schmidt, Christian, Viardot, Andreas, Bentz, Martin, Peter, Norma, Ehninger, Gerhard, Doelken, Gottfried, Ruebe, Christian, Truemper, Lorenz, Rosenwald, Andreas, Pfreundschuh, Michael, Loeffler, Markus and Glass, Bertram (2012). Conventional chemotherapy (CHOEP-14) with rituximab or high-dose chemotherapy (MegaCHOEP) with rituximab for young, high-risk patients with aggressive B-cell lymphoma: an open-label, randomised, phase 3 trial (DSHNHL 2002-1). Lancet Oncol., 13 (12). S. 1250 - 1260. NEW YORK: ELSEVIER SCIENCE INC. ISSN 1470-2045
2011
Behringer, Karolin, Thielen, Indra, Mueller, Horst, Goergen, Helen, Eibl, Angelika, Rosenbrock, Johannes, Halbsguth, Teresa, Reiners, Katrin S., Diehl, Volker, Engert, Andreas and Borchmann, Peter (2011). Fertility and Gonadal Function After Treatment of Early Unfavorable Hodgkin Lymphoma (HL): An Analysis of the German Hodgkin Study Group (GHSG). Blood, 118 (21). S. 199 - 200. WASHINGTON: AMER SOC HEMATOLOGY. ISSN 0006-4971
Boell, Boris, Bredenfeld, Henning, Goergen, Helen, Halbsguth, Teresa, Eich, Hans T., Soekler, Martin, Markova, Jana, Keller, Ulrich, Graeven, Ullrich, Kremers, Stephan, Geissler, Michael, Trenn, Guido, Fuchs, Michael, von Tresckow, Bastian, Eichenauer, Dennis A., Borchmann, Peter and Engert, Andreas (2011). Phase 2 study of PVAG (prednisone, vinblastine, doxorubicin, gemcitabine) in elderly patients with early unfavorable or advanced stage Hodgkin lymphoma. Blood, 118 (24). S. 6292 - 6299. WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020
Borchmann, Peter, Engert, Andreas and Diehl, Volker (2011). CHEMOTHERAPY Hodgkin lymphoma-absence of evidence not evidence of absence! Nat. Rev. Clin. Oncol., 8 (11). S. 636 - 639. NEW YORK: NATURE PUBLISHING GROUP. ISSN 1759-4774
Borchmann, Peter, Goekbuget, Nicola, Wulf, Gerald and Truemper, Lorenz (2011). Lymphoid neoplasms in young Patients. Onkologie, 34. S. 6 - 12. BASEL: KARGER. ISSN 1423-0240
Borchmann, Peter, Haverkamp, Heinz ORCID: 0000-0001-6895-4132, Diehl, Volker, Cerny, Thomas, Markova, Jana, Ho, Anthony D., Eich, Hans-Theodor, Mueller-Hermelink, Hans Konrad, Kanz, Lothar, Greil, Richard, Rank, Andreas, Paulus, Ursula, Smardova, Lenka, Huber, Christoph, Doerken, Bernd, Nerl, Christoph, Krause, Stefan W., Mueller, Rolf-Peter, Fuchs, Michael and Engert, Andreas (2011). Eight Cycles of Escalated-Dose BEACOPP Compared With Four Cycles of Escalated-Dose BEACOPP Followed by Four Cycles of Baseline-Dose BEACOPP With or Without Radiotherapy in Patients With Advanced-Stage Hodgkin's Lymphoma: Final Analysis of the HD12 Trial of the German Hodgkin Study Group. J. Clin. Oncol., 29 (32). S. 4234 - 4243. ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. ISSN 0732-183X
Eichenauer, Dennis A., Fuchs, Michael, Pluetschow, Annette, Klimm, Beate, Halbsguth, Teresa, Boell, Boris, Von Tresckow, Bastian, Nogova, Lucia, Borchmann, Peter and Engert, Andreas (2011). Phase 2 study of rituximab in newly diagnosed stage IA nodular lymphocyte-predominant Hodgkin lymphoma: a report from the German Hodgkin Study Group. Blood, 118 (16). S. 4363 - 4366. WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020
Eichenauer, Dennis A., Fuchs, Michael, Pluetschow, Annette, Klimm, Beate, Halbsguth, Teresa, Boell, Boris, von Tresckow, Bastian, Borchmann, Peter and Engert, Andreas (2011). Phase II Study of Rituximab in Newly Diagnosed Stage IA Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL): A Report From the German Hodgkin Study Group (GHSG). Blood, 118 (21). S. 1166 - 1168. WASHINGTON: AMER SOC HEMATOLOGY. ISSN 0006-4971
Engert, Andreas, Haverkamp, Heinz, Kobe, Carsten, Markova, Jana, Renner, Christoph, Ho, Anthony D., Zijlstra, Josee, Kral, Zdenek, Stein, Harald, Eich, Hans Theodor, Mueller, Rolf-Peter, Dietlein, Markus, Borchmann, Peter and Diehl, Volker (2011). Reduced Intensity of Chemotherapy and PET-Guided Radiotherapy in Patients with Advanced Stage Hodgkin Lymphoma: The GHSG HD15 Final Results. Blood, 118 (21). S. 271 - 272. WASHINGTON: AMER SOC HEMATOLOGY. ISSN 0006-4971
Halbsguth, Teresa V., Boell, Boris, Borchmann, Peter and Diehl, Volker (2011). The Unique Characteristics and Management of Patients Over 60 Years of Age with Classic Hodgkin Lymphoma. Curr. Hematol. Malig. Rep., 6 (3). S. 164 - 172. PHILADELPHIA: CURRENT MEDICINE GROUP. ISSN 1558-822X
Klimm, Beate, Franklin, Jeremy ORCID: 0000-0003-1536-0925, Stein, Harald, Eichenauer, Dennis A., Haverkamp, Heinz ORCID: 0000-0001-6895-4132, Diehl, Volker, Fuchs, Michael, Borchmann, Peter and Engert, Andreas (2011). Lymphocyte-Depleted Classical Hodgkin's Lymphoma: A Comprehensive Analysis From the German Hodgkin Study Group. J. Clin. Oncol., 29 (29). S. 3914 - 3921. ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. ISSN 1527-7755
2010
Boell, Boris, Borchmann, Peter and Diehl, Volker (2010). Emerging drugs for Hodgkin's lymphoma. Expert Opin Emerg. Drugs, 15 (4). S. 585 - 596. ABINGDON: TAYLOR & FRANCIS LTD. ISSN 1744-7623
Boll, Boris, Gorgen, Helen, Fuchs, Michael, von Tresckow, Bastian, Engert, Andreas and Borchmann, Peter (2010). Feasibility and Efficacy of ABVD In Elderly Hodgkin Lymphoma Patients: Analysis of Two Randomized Prospective Multicenter Trials of the German Hodgkin Study Group (HD10 and HD11). Blood, 116 (21). S. 186 - 188. WASHINGTON: AMER SOC HEMATOLOGY. ISSN 0006-4971
Borchmann, Peter (2010). Caring beyond cure: quality of life after high-dose chemotherapy for patients with relapsed Hodgkin lymphoma. Leuk. Lymphoma, 51 (11). S. 1949 - 1951. LONDON: INFORMA HEALTHCARE. ISSN 1042-8194
Borchmann, Peter and Engert, Andreas (2010). The Past: What We Have Learned in the Last Decade. Hematol.-Am. Soc. Hematol. Educ. Program. S. 101 - 108. WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1520-4383
Eich, Hans Theodor, Diehl, Volker, Goergen, Helen, Pabst, Thomas, Markova, Jana, Debus, Juergen, Ho, Anthony, Doerken, Bernd, Rank, Andreas, Grosu, Anca-Ligia, Wiegel, Thomas, Karstens, Johann Hinrich, Greil, Richard, Willich, Normann, Schmidberger, Heinz, Doehner, Hartmut, Borchmann, Peter, Mueller-Hermelink, Hans-Konrad, Mueller, Rolf-Peter and Engert, Andreas (2010). Intensified Chemotherapy and Dose-Reduced Involved-Field Radiotherapy in Patients With Early Unfavorable Hodgkin's Lymphoma: Final Analysis of the German Hodgkin Study Group HD11 Trial. J. Clin. Oncol., 28 (27). S. 4199 - 4207. ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. ISSN 1527-7755
Eichenauer, Dennis A., Haverkamp, Heinz, Behringer, Karolin, Halbsguth, Teresa, Fuchs, Michael, Diehl, Volker, Borchmann, Peter and Engert, Andreas (2010). Secondary MDS/AML In Hodgkin Lymphoma Patients Treated within German Hodgkin Study Group (GHSG) Clinical Trials After Introduction of the BEACOPP Protocol. Blood, 116 (21). S. 1105 - 1107. WASHINGTON: AMER SOC HEMATOLOGY. ISSN 0006-4971
Halbsguth, Teresa V., Nogova, Lucia, Mueller, Horst, Sieniawski, Michal, Eichenauer, Dennis A., Schober, Thomas, Nisters-Backes, Hiltrud, Borchmann, Peter, Diehl, Volker, Engert, Andreas and Josting, Andreas (2010). Phase 2 study of BACOPP (bleomycin, adriamycin, cyclophosphamide, vincristine, procarbazine, and prednisone) in older patients with Hodgkin lymphoma: a report from the German Hodgkin Study Group (GHSG). Blood, 116 (12). S. 2026 - 2033. WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020
Josting, Andreas, Mueller, Horst, Borchmann, Peter, Baars, Joke W., Metzner, Bernd ORCID: 0000-0002-1496-1377, Doehner, Hartmut, Aurer, Igor, Smardova, Lenka, Fischer, Thomas, Niederwieser, Dietger, Schaefer-Eckart, Kerstin, Schmitz, Norbert, Sureda, Anna, Glossmann, Jan, Diehl, Volker, DeJong, Daphne, Hansmann, Martin-Leo, Raemaekers, John and Engert, Andreas (2010). Dose Intensity of Chemotherapy in Patients With Relapsed Hodgkin's Lymphoma. J. Clin. Oncol., 28 (34). S. 5074 - 5081. ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. ISSN 1527-7755